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ABSTRACT 
Medical diagnosis is the process of attempting to determine and/or identify a 
possible disease or disorder. This process is revealed by biomarkers, defined 
by The Food and Drug Administration (FDA) as “characteristics that are 
objectively measured and evaluated as indicators of normal biologic 
processes, pathogenic processes, or pharmacologic responses to a 
therapeutic intervention”. The process of biomarker discovery has been 
boosted in the last years by proteomics, a research discipline that takes a 
snapshot of the entire wealth of proteins in an organism/ tissue/ cell/ body 
fluid. An implementation of the analysis methods can help in isolate proteins 
present in the low range of concentrations, such as biomarkers very often 
are. An established biomarker can further be measured with the help of 
biosensors, devices that can be employed in the point-of care diagnostics.  
This PhD thesis shows and discusses the results of three projects in the field 
of protein biomarkers discovery and quantification. The first  project exploited 
proteomics techniques to find relevant protein markers for Intrauterine 
Growth Restriction (IUGR) in cordonal blood serum (UCS) and amniotic 
fluid (AF). A 14 proteins in UCS and 11 in AF were successfully identified and 
found to be differentially expressed. 
Molecularly Imprinted Polymers (MIPs) directed towards proteins and 
peptides containing phosphotyrosine were then produced, with the final goal 
of selectively extracting phosphopeptides from a peptide mixture. An 
alteration of the phosphorylation pattern is in fact often associated to 
important diseases such as cancer. The polymers were produced as 
nanoparticles, that were characterised with Dynamic Light Scattering (DLS) 
and Atomic Force Microscopy (AFM). A recipe was also tested for binding 
capacity towards phosphotyrosine.   
A Surface Plasmon Resonance (SPR) biosensor to quantify hepcidin 
hormone was finally produced. This is the major subject in iron homeostasis 
in vertebrates and marker of iron unbalance diseases. A calibration curve 
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was made and affinity/kinetic parameters for the ligand employed were 
measured. 
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AIM AND OBJECTIVES OF THE THESIS 
 
The general outline of my 3 year PhD period work focuses on the discovery 
and quantification of protein biomarkers. This general aim is branched in 
different research subjects. 
Medical diagnosis is the process of attempting to determine and/or identify a 
possible disease or disorder. Diagnostics has made many steps forward in 
the last decades with the advent and progress of powerful techniques, such 
as imaging techniques (NMR, PET), mass spectrometry, bioinformatics and 
genomic tools. Big leaps have been made also specifically in the biochemical 
field, particularly in the identification and quantitative evaluation of molecules 
whose presence in the human body increases or decreases following a 
pathological condition.  
The Food and Drug Administration (FDA) defines a biomarker as “a 
characteristic that is objectively measured and evaluated as an indicator of 
normal biologic processes, pathogenic processes, or pharmacologic 
responses to a therapeutic intervention”. Biomarker discovery is a long 
process which starts from the study of the characteristics of the organism of 
interest. The genomic approach reveals the potential characteristics of the 
organism, subsequently expressed in a protein pattern through the 
transcriptional and translational steps, eventually followed by the post-
translational modifications.  
The “proteome” is defined as the entire wealth of PROTEins expressed by 
the genOME. This is a very kaleidoscopic entity, different from subject to 
subject and different in different stages of life, or in different situations to 
which an organism can be exposed. Proteins are subjected to Post 
Translational Modifications (PTMs, e.g. glycosylation, phosphorylation, 
deamidation, splicing) and these runaway modifications often correlate with 
alterations from the normal setup. A proteomic approach takes a picture of a 
particular stage of life of an organism, and permits a comparison to be made 
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between the different general protein patterns in different situations, e.g. from 
a normal to a disease state. 
Due to the large number of different proteins (thousands in a single cell) and 
their high differential expression (which can span 10 orders of magnitude in 
human blood) a single stage of separation is not sufficient to analyze them 
singularly. First of all prefractionation techniques to separate different parts of 
a cell (membrane, cytosol, nuclei, etc.) or different fractions of a liquid (blood, 
urine, cerebrospinal fluid, synovial fluid) are needed to reduce the complexity. 
Then orthogonal techniques have to be applied. These techniques exploit the 
different physical-chemical characteristics of proteins, e.g. molecular mass, 
isoelectric point, hydrophilicity. Nowadays the most established technique to 
take a snapshot of this changing entity is 2D gel electrophoresis (2-DE). 
Other orthogonal techniques are being used as well. MudPIT 
(Multidimensional Protein Identification Technology), for example, combines 
Strong Cation Exchange chromatography (SCX) and Reversed Phase 
chromatography (RP) to separate proteins and peptides in liquid phase on-
line, and has the advantage to be directly interfaced to a mass spectrometer 
(MS) improving sensitivity and resolution. 
Particular fractions of the proteome can be separately analysed. One 
important case is phosphorylation, the most widespread and studied PTM. 
Also in this case there are most established techniques to selectively catch 
and analyse phosphorylated proteins and peptides, with the aim of 
characterising phosphorylation pathways and finding abnormalities in their 
regulation, frequently in many diseases such as cancer or 
neurodegeneration. In order to improve our understanding of these networks, 
and with the aim of finding new drug targets or biomarkers, improvements at 
all levels of the analysis are needed. One critical step is the enrichment of 
phosphopeptides, which is currently not efficient enough to allow for a 
comprehensive coverage of this chemically heterogeneous class of 
molecules. 
Once a protein or peptide of biological value is found, its relevance as a 
biomarker has to be validated against a wide group of subjects. Then its 
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routine measurement can be included in health screenings, possibly carried 
out with fast and cheap methods. Regarding this goal, biosensors can be 
particularly suitable. These are devices made of: a bioreceptor molecule, able 
to bind to or react with the analyte of interest; a transducing system that 
converts the biological event into an electric signal, and a data analysis 
system, that processes this signal in order to display the measured 
parameter(s) to the operator. These devices generally have the advantage 
that they can be employed directly where needed, i.e. at or near the patient, 
in what is called “point-of-care diagnostics”. This could reduce the time to 
make clinical management decisions.  
My 3 years PhD period has evolved in this panorama, spanning from the 
biomarkers/drug targets discovery to assays/biosensors development. 
The first project that I followed exploited proteomic techniques with the 
objective of finding relevant protein markers for Intrauterine Growth 
Restriction (IUGR) in cordonal blood and amniotic fluid, to shed some light on 
the pathology mechanisms and to furnish a tool for an early diagnosis of the 
disease. The pathology has great relevance, being present in 4% of all 
pregnancies and strongly related to stillbirth. The biochemical markers 
already used in clinics are not precise enough in the diagnosis, therefore a 
proteomic screen seemed to be the right approach in order to take a 
snapshot of the alteration of the protein pattern and find new potential clinical 
markers.  
I then moved onto the production of Molecularly Imprinted Polymers, with the 
final goal of selectively extracting phosphopeptides from a peptide mixture 
and thus find alternatives for the grasp of the phosphoproteome. 
Improvements at all levels of phosphoproteomics are in fact needed. In 
particular, new materials could help in the step of sample enrichment. 
Phosphoproteins and phosphopeptides are in fact highly underrepresented 
with respect to their non-phosphorylated counterparts and the currently used 
materials catch only a fraction of their chemically heterogeneous population.    
Finally I stepped into the biosensors field, focusing my work on the detection 
and quantification of hepcidin peptide hormone. This is the major subject in 
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iron homeostasis in vertebrates and of marker of iron imbalance diseases. 
The problem has an outstanding clinical relevance, given that anemias affect 
over one-half billion people all over the world. The recently discovered 
hepcidin hormone showed problems in its measurement, given its 
chemical/physical characteristics. The approach that I followed was the 
development of an SPR biosensor through the use of part of its natural 
receptor on macrophages and duodenal enterocells: the hepcidin binding 
domain on ferroportin. This seemed to be a promising way to tackle the 
problem and introduce a potential point-of-care testing device into the clinic. 
All this work has been done keeping fixed one idea in my mind: everybody 
that works in this field faces the challenge and has the inspiring aim of 
improving, maybe just a bit and in a not immediately clear way, the health of 
all of us. 
The proteomics work discussed in this thesis was carried out in the Mass 
Spectrometry and Proteomics lab at the Biotechnology Department of the 
University of Verona (Italy), in collaboration with the Department of 
Environmental Medicine and Public Health and the Department of 
Gynecological Sciences and Reproductive Medicine of Padova (Italy), that 
provided the biological samples. This study was approved by the Ethical 
Committee of Padova University Hospital, after obtaining written informed 
consent from the mothers of the foetuses. 
The work on Molecularly Imprinted Polymers and the development of the 
SPR biosensor was performed in the Biochemical Methodologies and 
Molecular Imprinting Laboratory at the Biotechnology Department of 
University of Verona (Italy) and in the School of Cranfield Health of Cranfield 
University (Bedfordshire, UK). The results obtained are here discussed and 
evaluated. 
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1 CHAPTER 
 
DISCOVERY OF NEW PROTEIN MARKERS FOR INTRAUTERINE 
GROWTH RESTRICTION 
 
1.1 Introduction 
Foetus growth is a complex process driven basically by four factors: maternal, 
placental, genetic and external (Gardosi J, 2006). All these factors are 
intimately correlated in determining a harmonic growth of the foetus. An 
unbalance of one or more of them can determine lesser or greater alterations in 
the foetus’ wellbeing. In modern hospitals foetus growth is monitored throughout 
the pregnancy with several exams at well determined periods of the expected 
40 weeks of gestation. Ecography is the most renowned method, by which 
different metric parameters are measured: head circumference (HC), bipariethal 
diameter (BPD), femur length (FL), abdominal circumference (AC), crown-rump 
length (CRL) and humerus length (HL) (Fig. 1-1) (Mandruzzato G, 2008). Other 
routine exams are cardiotocography (foetus heart beat), eco-Doppler 
(evaluation of blood flux from mother to foetus and vice-versa) and mother’s 
urine and blood analysis (biochemical analysis). 
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Fig. 1-1. Foetal segmentation measured through ecography: A) BPD, B) HC, C) 
AC, D) FL, E) HL, F) CRL (Pictures taken from: Carneiro G, Georgescu B, Good S, 
Comaniciu D, IEEE Transactions on Medical Imaging 2008, 27, 1342-1355). 
 
The foetus weight is normally estimated through ecographic measurements, 
e.g. AC as single parameter has a good correlation with the weight 
(Mandruzzato G, 2008) and  normally follows a sigmoidal trend, therefore it is 
more pronounced in the middle of the gestational period (Fig. 1-2). Customised 
growth charts made on homogeneous populations are available and are used in 
order to assess the normal increase of the foetus weight (Breeze ACG, 2007).  
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Fig. 1-2. Sigmoidal trend of foetus’ weight increase during the gestational period 
(Picture taken from: Peleg D, Kennedy CM, Hunter SK. Am Fam 
Physician. 1998 Aug 1;58(2):453-460). 
 
When the weight is less than the 10th customised centile we speak about a 
small for gestational age foetus (SGA). This small size can be physiological, i.e. 
due to factors like parity or altitude that normally reduce the weight, otherwise a 
pathological condition can be present and it has to be carefully considered by 
obstetricians. In this case we speak about intrauterine growth restriction (IUGR).  
The discrimination between SGA and IUGR is normally determined through a 
series of ecographic measurements with 2 weeks of delay between 
measurements: if the growth shows an accentuated slowdown, a pathological 
condition is present, and actions have to be taken in order to secure the best 
health condition for the foetus and the mother. This condition is in fact related to 
serious problems for the foetus, both perinatally, carrying increased morbidity 
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and mortality, and in adult life, bringing metabolic and cognitive deficits 
(Bernstein G, 2000). Apart from cases where hormonal therapy is effective (Hui 
L, 2008) no proven therapy in uterus is nowadays available, and a decision has 
to be taken whether to let the foetus grow in adverse conditions or program the 
delivery. This decision is normally taken considering the gestational age, which 
has to be evaluated as more precisely as possible (Mandruzzato G, 2008). 
Obstetrical management is therefore critical, and subjected to regulation by law 
and juridical disputes. In this context legal medicine plays a role in ascertaining 
when an improper obstetrical management was present, having consequences 
as health problems of the foetus and/or the mother (Loue S). The growing 
number of juridical disputes raises the need of a precise determination of the 
period when the pathological condition emerged (damage timing) and if it was 
not seen. This determination can be made a posteriori, evaluating the presence 
of biomarkers in cordonal blood serum or amniotic fluid.  
Amniotic fluid (AF), routinely used for prenatal diagnosis, contains large 
amounts of proteins produced by the amnion epithelial cells, foetal tissues, 
foetal excretions, and placental tissues. Additionally, molecules originating from 
maternal circulation are released in the amniotic cavity. The biochemical 
composition of AF is modified throughout pregnancy and its protein profile 
reflects both physiological and pathological changes affecting the foetus and the 
mother (Jauniaux E, 1994, Kolialexi A, 2007). Identification of changes in the 
balance of proteins, therefore, may be used to detect a particular type of 
pathology, or to identify a specific genetic disorder. Potential biomarkers in AF 
have already been identified in cases of inflammation and premature rupture of 
foetal membranes (Brenner, 2004, Vuadens F, 2003). 
Umbilical cord (UC) blood drawn from the doubly clamped umbilical cord at 
delivery reflects the foetal blood compartment. Along these lines, the cord blood 
levels of various growth factors and hormones have been related to size at birth 
by several groups (Amarilyo G, 2010, Neta GI, 2010). Protein S100B is a 
recently identified UC blood protein able to assess newborn brain damage 
(Gazzolo D, 2004). Other established markers of anoxia are umbilical cord 
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blood pH, uric acid, cytokines and lactate levels in umbilical vein (Hellstrom-
Westas L, 1995, Huang CC, 1999). 
The purpose of this project is to investigate the differential protein expression 
levels in UC serum (UCS) and amniotic fluid (AF) in IUGR, to produce 
information on the causes and mechanisms of prenatal disorders and reveal 
possible markers for postnatal complications and disease progression. 
Moreover, as said before, new markers for precision and accuracy improvement 
of damage timing are needed, in order to assess possible responsibilities of an 
improper obstetrical treatment. 
The chosen experimental technique is two-dimensional polyacrylamide gel 
electrophoresis (2D-PAGE), a well-established tool for proteomic analysis that 
can be used to compare patterns of protein expression in various biological 
materials under physiological and pathological conditions. MS, in association 
with bioinformatics, provides the tool for the identification of protein spots on 
2D-PAGE maps. In the next paragraph this technique will be explained in detail. 
1.2 Two-dimensional gel electrophoresis (2D-PAGE) 
In 2D-PAGE proteins in a sample are separated in two dimensions according 
respectively to their isoelectric point (pI) and molecular mass (MW). The 
technique includes sample preparation, protein separation through gel 
electrophoresis, protein detection, digestion of the differentially expressed 
proteins and their identification with MS and bioinformatic tools (Fig. 1-3). 
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Fig. 1-3. Workflow of a clinical proteomics analysis, i.e. regarding clinical 
samples and molecular medicine studies. MALDI: Matrix Assisted Laser 
Desorption Ionisation; ESI: Electrospray Ionisation. 
1.2.1 Sample preparation 
Normally as a first step proteins are extracted from a complex medium, such as 
a cell culture or a body fluid, and treated to remove impurities such as nucleic 
acids, lipids, salts and sugars. This step can be done for example on serum 
samples through acetone precipitation and centrifugation: impurities will be 
mostly present in the supernatant and proteins can be isolated as a pellet. 
These are subsequently solubilised in a highly dispersive media, such as 7M 
urea, 2M thiourea plus 3% surfactant (e.g. 3[(3-cholamidopropyl) 
dimethylammonium]-1-propanesulfonate, “CHAPS”, a sulfobetainic zwitterionic 
detergent) Tris buffer. In order to remove nucleic acids a prolonged 
centrifugation at high speed (e.g.14000 x g x 40’) is usually effective, otherwise 
the use of  ampholytes can suit the purpose of precipitating them, subsequently 
removed by centrifugation. In order to improve solubilisation, sulphur bridges 
are broken by the use of a reducing agent, such as tributhylphosphine (TBP) 
 7 
and –SH groups are prevented from reforming links through iodoacetamide or 
acrylamide (AA) blocking. This operation also avoids the creation of fake omo 
and etero-oligomers due to –SH recombination (Harry JL, 2000). 
1.2.2 Protein separation 
The samples are then loaded onto polyacrylamide strips with an immobilised pH 
gradient (IPG strips) and the applied voltage induces proteins to migrate 
depending on their charge, along the strip. When they are in a region where the 
pH corresponds to their pI they stop, due to a null net charge. This first 
separation is further amplified with a second dimension. The IPG strips are 
equilibrated in a solution containing sodium dodecyl sulphate (SDS), which 
binds to proteins proportionally to the number of amino acid residues (about 1 
SDS molecule for every 2 residues), conferring to every protein a negative 
charge proportional to its molecular weight. The strip is then interfaced on a 
side of a polyacrylamide gel slab through agarose gel bridging. A second 
electrophoretic migration along the gel matrix separates proteins with the same 
pI but different MW. More maps are produced with different samples to evaluate 
the statistical variation, both analytical and biological. 
1.2.3 Detection of proteins 
Protein spots in the gel are then stained to be visualised and therefore to 
evaluate protein amounts. A common stain is colloidal Coomassie blue (Neuhoff 
V, 1988), while other stains are SyproRuby. RuBPS (both fluorescent) (Yan JX, 
2000) and Silver staining (the most sensitive but at the same time difficult to 
control for not reaching an equilibrium in the staining process) (Shevchenko A, 
1996). Each of these methods is compatible with the downstream MS analysis. 
The gel images are then acquired and digitised, to be further analysed with 
dedicated software such as PDQuest, Melanie, Phoretic and Progenesis Gel 
images are superimposed to match protein spots, in order to compare quantities 
of the same protein between the gels and find modulations of expression 
between groups of samples. The level of appreciable differential expression 
depends on the number of replicates, e.g. with 10 replicates a 1.5 times 
modulation is appreciable (Hunt SMN, 2005). 
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1.2.4 Protein digestion 
Once protein spots with a significant differential expression have been found 
their identity needs to be inferred. MS methods are the most powerful and 
versatile available with this purpose. First of all the protein spots need to be cut 
out from the gel, then they are submitted to proteolytic digestion with an enzyme 
such as trypsin, that cleaves peptide bonds in proximity of a C-terminal lysine or 
arginine and generates peptides of suitable length for MS analysis (Fig. 1-4). 
 
Fig. 1-4. Mass Spectroscopy methods. In proteomics mostly MALDI and ESI 
methods are used to ionise proteins and/or peptides, subsequently fragmented 
to give a MS1 spectrum. A further fragmentation of the most abundant peptides 
gives the MS2 spectrum. 
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1.2.5 Protein identification 
The identification of proteins through mass spectroscopy relies on the accurate 
measurement of protein and peptide masses. 
A mass spectrometer is a device made essentially of three components:  
1) an ionizing source, that in this case ionises proteins and peptides;  
2) a mass analyser, that resolves the ions in dependence of their mass/charge 
ratio (m/z);  
3) a detector, that reveals the ions resolved by the mass analyser.  
In proteomic studies two ionisation methods are generally employed: Matrix 
Assisted Laser Desorption Ionisation (MALDI) and Electrospray Ionisation (ESI) 
(Chen, 2008). In MALDI peptides are co-crystallised in a matrix with molecules 
such as sinapinic acid or alpha-cyano-4-hydroxycinnamic acid. A laser impulse 
then softly desorbs and ionises the peptides, whose m/z is measured, usually 
with Time-Of-Flight detectors (TOF). The combination of more peptide masses 
is associated with a specific protein (peptide fingerprint). In order to deepen the 
analysis a further fragmentation of peptides can be performed, via a second 
collision chamber and another TOF analyser (MALDI-TOF/TOF). The collision 
with helium atoms, electrons or other collision agents such as electron 
transferring molecules induces the backbone fragmentation in correspondence 
of peptide bonds, permitting to infer the peptide sequence through calculation of 
mass difference of adjacent peaks (tandem MS/MS). 
In ESI-MS, instead, peptides firstly separated with an HPLC column are ionised 
with an electrospray system. The preferred detectors for this system are Ion 
Trap (IT) and triple quadrupole (QQQ). 
The peptide sequence is the first step in protein identification, and its reliability 
is expressed through a score, calculated as S= -10Log10(p). The parameter p is 
the probability that a sequence match between MS and database data is a 
random event, and is given by the ratio between the significance threshold of 
random match chosen E and the number of proteins in the database N. 
For example, if during a search 500,000 peptides fell within the window of mass 
tolerance chosen and the significance threshold chosen is 0.05 (1 in a 20 
chance to be a false positive) the corresponding score threshold would be S= -
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10Log10(E/N) -10Log10(0.05/500000)= 70. The protein score is given by the sum 
of the scores of individual peptides.  
Other parameters to be included in mass spectrum analysis are mass tolerance, 
the presence of modifications (e.g. –SH blocking with AA) and the N- or C-
terminal amino acid depending on the lysing enzyme used. The mass spectrum 
is a forest of peaks, and the highest are submitted to further fragmentation. The 
results of fragmentation are analysed with software packages such as MASCOT 
(at the Matrix Science server) or SEQUEST to correlate the peptide sequences 
with those usually derived from genomic data. These data can be found in 
dedicated protein databases such as SWISSPROT maintained by the Swiss 
Institute for Bioinformatics and the European Bioinformatics Institute, or the 
USA government-funded National Center for Biotechnology Information (NCBI).  
A successful protein identification depends on many parameters, such as the 
number of successfully identified peptides, their uniqueness for a protein and 
the sequence coverage. Nevertheless there can be ambiguities, and a 100% 
assignment is not always possible (that is why mass spectroscopists speak 
about “correlation” and not “identification”) (Chen, 2008). A MASCOT score for 
a peptide above 30 is usually considered enough to have a good correlation. 
1.2.6 Bioinformatics 
Once a reasonable correlation between MS data and a protein has been 
obtained, it becomes a potential candidate as a marker of disease or of drug 
treatment. In order to have a complete understanding of its role, its molecular 
functions (e.g. enzyme), cellular or extracellular districts where it is present (e.g. 
cytoplasma) and biological processes in which it is involved (e.g. glucose 
oxidation) need to be known. This study, called Gene Ontology (GO) can be 
performed with one of the many software packages available, such as 
SWISSPROT or GeneCards, curated by the Crown Human Genomic Centre at 
the Weizmann Institute of Science in Israel (Bairoch A, 2000). 
The next step is inserting the protein in the nets of processes in which it is 
involved, this time with the help of dedicated software packages such as Kioto 
Encyclopedia of Genes and Genomes (KEGG, hosting more than 150,000 
pathway maps) or Reactome. 
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1.3 Materials and methods 
1.3.1 Umbilical cord blood and amniotic fluid withdraw  
The study, approved by the Ethical Committee of Padova University Hospital 
(Padova, Italy), was performed after obtaining written informed consent from the 
mothers of the foetuses. Ten IUGR and ten AGA full-term singleton neonates, 
all of Italian origin, were included in the study. Offspring of mothers with a birth 
weight below the 10th customised centile were characterised as IUGR. The 
Gestation Related Optimal Weight computer-generated program was used to 
calculate the customised centile for each pregnancy, taking into consideration 
significant determinants of birth weight, such as maternal height and booking 
weight, ethnic group, parity, gestational age and gender. The choice of the 
neonates excluded the cases where a chromosomal pathology, child-dependent 
disease or maternal consumption of xenobiotics were present. 
Umbilical cord blood samples (UCS) were withdrawn from double clamped 
umbilical cord of singletons, from full-term deliveries performed with caesarean 
section. UCS was obtained after clotting for 30-45 min at room temperature 
followed by centrifugation at 3000g for 20 min in BD Vacutainer® glass serum 
tube, then samples were added to protease inhibitors (Roche) and frozen 
straightaway at -80°C until the analysis. 
Amniotic fluid (AF) samples were obtained through withdrawal by syringe after 
amniotic sac resection, and treated with the same procedure as serum, omitting 
the clotting step. 
1.3.2 Protein sample preparation 
The samples of UCS were albumin and IgG depleted (with ProteoPrep Blue 
Depletion kit, Sigma). Proteins, from UCS and AF, were precipitated with 4 
volumes of acetone at -20°C for 2 h and then resuspended in a solubilising 
solution: 7 M urea (Sigma, Sigma-Aldrich Corporation, St. Louis, MO, USA), 2 
M thiourea (Sigma), 3% CHAPS (Sigma), and 20 mM Tris (Sigma). 
Centrifugation at 14000 x g at 4°C for 40 min was performed to get rid of 
incidentally present nucleic acids.  
The samples were then incubated with 5 mM tributylphosphine (Sigma) and 20 
mM acrylamide (Sigma) for 60 minutes at room temperature to reduce protein 
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disulphide bonds and alkylate the cysteine thiolic groups. The reaction was 
blocked by the addition of 10 mM ditiothreitol (DTT, Sigma). Protein 
concentration was evaluated by Detergent Compatible (DC) Protein assay (Bio-
Rad Labs., Hercules, CA, USA) based on the Lowry method. 
 
1.3.3 Two-dimensional gel electrophoresis and image analysis 
UCS and AF protein fractionation by 2-DE were performed as reported by 
Cecconi el al. (Cecconi D, 2008). Briefly, 450 µl of each sample (containing 3 
mg/ml of protein) was separated by 17 cm pH 3-10 NL IPG strip, and the total 
product time x voltage applied was 70000 Vh for each strip. The second 
dimensional separation was done using 8-18%T gradient SDS-PAGE, applying 
40 mA for each gel for 3 min, then 2 mA/gel for 1 h, and 20 mA/gel until the 
track dye, bromophenol-blue, reached the anodic end of the gels. After 2-DE, 
the proteins were detected by Sypro Ruby. The image analysis of the 2D gels 
replicates was performed by PDQuest software (Bio-Rad), version 7.3. Each gel 
was analysed for spot detection, background subtraction and protein spot 
optical density (OD) intensity quantification. The gel image showing the highest 
number of spots and the best protein pattern was chosen as a reference 
template, and spots in this standard gel were then matched across all gels. Spot 
quantity values were normalised in each gel by dividing the raw quantity of each 
spot by the total quantity of all the spots included in the standard gel. Gels were 
divided in two groups (control and IUGR samples) and, for each protein spot, 
the average spot quantity value and its variance coefficient in each group were 
determined. Data were log transformed and analysed with Student’s t-test, then 
spots giving significant results (p < 0.01) were verified visually to exclude 
artefacts. 
1.3.4 Mass spectrometry and protein identification 
Spots showing a statistically significant differential expression were carefully cut 
out from 2-D Sypro Ruby stained gels and subjected to in-gel trypsin digestion 
(Neuhoff V, 1988). Briefly, spots were destained with three washing steps: 
50mM NH4HCO3, 50% 50mM NH4HCO3 (v/v), 50% acetonitrile, 100% 
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acetonitrile, and dried at 37°C for 30 min. The gel pieces were then swollen in 
digestion buffer containing 50mM NH4CO3 and 12.5ng/ml of trypsin (modified 
porcine trypsin, Promega, Madison, WI) and the digestion proceeded at 37°C 
overnight. The supernatants were collected and peptides were extracted in an 
ultrasonic bath (twice with 50% acetonitrile, 50% H2O v/v with 1% formic acid, 
once with acetonitrile). Finally tryptic peptides were dried by vacuum 
centrifugation. Peptides from 8 μl of each sample were then separated by 
reversed phase (RP) nano-HPLC-Chip technology (Agilent Technologies, Palo 
Alto, CA, USA) online-coupled with a 3D ion trap mass spectrometer (model 
Esquire 6000, Bruker Daltonics, Bremen, Germany). The chip was composed of 
a Zorbax 300SB-C18 (150mm × 75m, with a 5m particle size) analytical 
column and a Zorbax 300SB-C18 (40 nL, 5m) enrichment column. The 
complete system was fully controlled by ChemStation (Agilent Technologies) 
and EsquireControl (Bruker Daltonics) software. The scan range used was from 
300 to 1800 m/z. For tandem MS experiments, the system was operated with 
automatic switching between MS and MS/MS modes. The three most abundant 
peptides of each m/z were selected to be further isolated and fragmented. The 
MS/MS scanning was performed in the normal resolution mode at a scan rate of 
13,000 m/z per second. A total of five scans were averaged to obtain an MS/MS 
spectrum. Database searches were conducted using the MS/MS ion search of 
Mascot against all entries of the non-redundant NCBI database with the 
following parameters: specific trypsin digestion, up to one missed cleavage; 
fixed and variable modifications: propionamide (Cys) and oxidation (Met), 
respectively; peptide and fragment tolerances: ± 0.9 Da and ± 0.9 Da, 
respectively, and peptide charges: +1, +2 and +3. For positive identification, the 
score of the result of [- 10 x Log10(p)] had to be over the significance threshold 
level (p < 0.01) and at least 2 different peptides (p < 0.05) had to be assigned. 
1.3.5 Protein validation by Western Blot analysis  
Protein samples were precipitated with cold acetone at -20°C for 2 hours and 
centrifuged at 14,000 x g for 10 min. The pellets obtained were dried and 
resuspended with Laemmli’s sample buffer (62.5 mM Tris-HCl, pH 6.8, 25% 
glycerol, 2% SDS, 0.01% Bromophenol Blue, 5% ß-mercaptoethanol) through 5 
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min heating in boiling water. A 1-D SDS-PAGE separation on 10%T acrylamide 
gel in Tris/glycine/SDS buffer was then performed. The separated proteins were 
transferred to a PVDF membrane through electroblotting and equal protein 
loading in each lane (60 g) was verified by Ponceau red staining. The 
membranes were treated with primary and secondary antibodies at the 
appropriate dilutions (see Tab. 1-2) and bound antibody was detected by 
Enhanced Chemiluminescence (ECL) Western blotting detection system 
(Millipore, USA). Western blots were scanned by a ChemiDoc instrument (Bio-
Rad) and images were analysed using Quantity One image processing software 
(Bio-Rad). 
1.3.6 Classification of Proteins  
Functional annotation was obtained by assignment of Gene Ontology (GO) 
terms for the identified proteins. GO analysis was performed with the help of 
GeneCards database (http://www.genecards.org), classifying each protein with 
respect to its molecular function and biological process in which it is involved. 
1.4 Results 
The typical high resolution 2-DE protein pattern of IUGR and control neonates, 
obtained from UCS and AF protein extracts, are reported in Fig. 1-5 and Fig. 
1-6. By PDQuest analysis we measured differential protein expression by 
analysing the 10 biological replicates of 2-DE maps obtained for each group.  
A total of 18 and 13 spots (matched across all the replica 2D maps) were found 
to be differentially expressed (p < 0.01) in UCS and AF respectively. Spots 
selected from the differential analysis were subjected to RP-HPLC-ESI-MS/MS 
analysis for protein identification.  
The unique differentially expressed proteins identified were 14 in UCS, and 11 
in AF samples. In Tab. 1-1, the successfully identified proteins corresponding to 
up- or down-regulated spots in UCS and AF are shown, together with the gene 
names, the standard spot number (SSP), the identification parameters and the 
indication of their gene ontology (GO) annotation (biological process and 
molecular function). Protein GO classification indicate that 21% of proteins are 
involved in inflammatory response, 20% in immune response, while a smaller 
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proportion are related to transport, blood pressure, and coagulation. Figure 8 
shows the distribution of the identified proteins as a pie chart, categorised 
according to the biological process in which they are involved.  
Western Blot analysis, performed to determine the level of expression of five 
candidate proteins (complement C3-alpha chain (C3), serotransferrin (TF), 
kininogen light chain (KNG1), apolipoprotein J (CLU), and angiotensinogen 
(AGT) identified by 2-DE analysis are shown in Fig. 1-7. The relative protein 
expression in both samples was normalised through staining with Ponceau Red 
which permits an appreciation of the total protein amount. Trends of changes in 
the same direction as those detected in the 2D gel analyses were detected for 
all the proteins. The quantitative difference between the results obtained by 2D 
electrophoresis and by Western Blot suggested that most changes detected by 
the former technique specifically involve post-translationally modified forms, 
which can be only separated in 2D maps (Fig. 1-5, Fig. 1-6). 
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Fig. 1-5. 2D-PAGE map of UCS with spots of differentially expressed proteins 
pinpointed with an SSP (Standard Spot numbering), assigned by PDQuest 
software).  
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Fig. 1-6. 2D-PAGE map of AF with spots of differentially expressed proteins 
pinpointed with an SSP (Standard Spot numbering), assigned by PDQuest 
software).  
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Tab. 1-1. Identified proteins that are differentially expressed in UCS and AF of 
IUGR newborns through 2-DE.  
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a) Spot numbers refer to 2D gels of Figure 1-5 and 1-6. 
b) Score is –10log10(p), where p is the probability that the observed match is a 
random event, 
based on the NCBI database using the MASCOT searching program as MS/MS 
data. 
c) Amino acid sequence coverage for the identified protein. 
d) Fold of variation in expression in IUGR/C ratio: increased protein (+), decreased 
protein(-).  
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Fig. 1-7. Protein expression validation with Western blot analysis for five 
proteins. Film images with the relative protein expression were normalised by 
Ponceau red staining. Film images were captured with GS710 densitometer (Bio-
Rad) and analysed with Quantity One software to calculate the band intensities 
(OD). 
 
Fig. 1-8. Protein GO categorisation. Distribution of the identified proteins 
according to the biological process(es) in which they are involved. GO analysis 
was performed by using GeneCards database. 
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Tab. 1-2. The different primary and secondary antibodies used for Western Blot 
analysis, with the corresponding dilutions.  
 
Primary antibody Dilution 
Mouse anti-complement C3B-alpha (Chemicon) 1:1000 
Mouse anti- angiotensinogen  (Abnova) 1:2000 
Mouse anti-transferrin HTF-14 (GeneTex) 1:1000 
Mouse anti-clusterin CLI-9 (GeneTex) 1:2000 
Rabbit anti-kininogen1 (GeneTex) 1:2000 
Secondary antibody Dilution 
Goat anti-mouse IgG, HRP conjugated (Millipore) 1:5000 
Donkey anti-rabbit IgG, HRP conjugated (Amersham) 1:10000 
 
1.5 Discussion 
The differentially expressed proteins identified in both umbilical cord serum and 
amniotic fluid samples of IUGR and AGA neonates are described and 
discussed in the following paragraphs. 
1.5.1 Coagulation and IUGR 
The association between coagulation disorders and IUGR has already been 
demonstrated by several publications (Bellart J, 1998, Benedetto C, 2010, 
Ducloy-Bouthors AS, 2010). A low grade activation of the coagulation system is 
in fact suggested as one possible factor in the pathogenesis of IUGR. 
Accordingly, it has been reported that heparin treatment significantly improved 
the growth of the growth-restricted foetus (Persson B L, 1982, Yu YH, 2010, Yu 
YH, 2004). Among the proteins that play a pivotal role in coagulation there is 
fibrinogen, which is converted by thrombin into fibrin to form a clot. Interestingly, 
it has been demonstrated that the G/A polymorphism at position - 455 of the 
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beta-fibrinogen gene may enhance the physiological increase in fibrinogen 
levels during pregnancy and thereby predispose to obstetric complications 
(Camilleri R S, 2004, von Tempelhoff G F, 2009). In line with these findings, we 
found that fibrinogen was up-regulated in UCS as well as in AF of IUGR 
samples. 
Another protein also related to coagulation is alpha 2-macroglobulin (A2M) 
which is a protease inhibitor with both anticoagulant and procoagulant 
properties (it neutralises alpha-thrombin, plasmin, and activates protein C) 
(Cvirn G, 2002). In some studies A2M has been negatively correlated with birth 
weight: infants with lower birth weight had higher cord serum A2M 
concentrations as compared to those with higher birth weight (Goldenberg RL, 
1991, Cliver SP, 1993). Our data stands in contrast with these findings, indeed 
we reported a down-regulation of A2M in UCS of mothers of IUGR infants. An 
explanation of this discrepancy may depend on the modulation of different PTM-
modified isoforms. 
1.5.2 Immune mechanisms and IUGR 
Another mechanism that seems to be involved in IUGR development is the 
inflammatory response, which interestingly has been linked to the coagulation 
process state (Lipinski S, 2010, Girardi G, 2008). Normal pregnancy is 
associated with increased concentrations of maternal plasma complement 
components. Complement activation may in fact compensate for the decreased 
adaptive immunity observed in normal pregnancy, and is aimed to protect the 
host (mother and/or foetus) from microorganisms and other potential antigens 
(Richani K, 2005, Tincani A, 2010). 
The available data on the relationship between complement activation and 
growth retardation appear to be conflicting: some studies have reported that 
complement levels were significantly lower in mothers of SGA infants than in 
controls (Labarrere C, 1985) suggesting that the immunological derangement 
leads to placental lesions and growth restriction. On the contrary, others 
indicate that complement activation is associated with IUGR and other 
pathological outcomes of pregnancy (such as preeclampsia and recurrent 
spontaneous abortions) (Labarrere CA, 1986). In particular, it has been reported 
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that C5 (Girardi G, 2008), as well as C3a activation (Lynch AM, 2010), are 
crucial intermediary events (in the first trimester of pregnancy) in the 
pathogenesis of IUGR. In this study we found that IUGR newborns are related 
to down-regulation of C3, C3b, C3c, C4 complement components in UCS, as 
well as down-regulation of complement factor B in AF samples respectively. Our 
findings emphasise the central role of complement proteins modulation as a key 
process implicated in poor pregnancy outcomes. 
1.5.3 Blood pressure alteration and IUGR 
Pregnancy is a physiological condition characterised by a progressive increase 
of the different components of the renal renin-angiotensin system (RAS). RAS is 
involved not only in the regulation of blood pressure and fluid-electrolyte 
homeostasis, but has also a role in the human placenta development 
throughout gestation: angiotensin II for example inhibits human trophoblast 
invasion (Xia Y, 2002). Alterations in RAS have been already observed in IUGR 
offspring and may play a key role in the aetiology of IUGR hypertension (Zohdi 
V, 2007, Grigore D, 2007). Interestingly, it has been reported that maternal and 
foetal angiotensinogen Thr235 genotypes are associated with an increased risk 
of IUGR (Zhang XQ, 2003, Zhang X, 2007), as well as of preeclampsia, which is 
a medical condition in which hypertension arises in pregnancy (Bouba I, 2003). 
Here we reported that angiotensinogen is down-regulated in UCS of IUGR 
newborns. Further studies are needed to understand whether the decreased 
angiotensinogen we identified is the Thr235 variant or not, and to prove whether 
the data obtained are consistent with previous reports from other workers. 
Another protein related to blood pressure control is kininogen, which belong to 
plasma kallikrein-kinin system (KKS) that plays a role not only in blood pressure 
(via modulation of RAS system), but also in inflammation, coagulation and pain. 
Kininogen is a thiol protease that circulate as two different isoforms produced by 
alternative splicing, high molecular weight (HK) and low molecular weight 
kininogen (LK). Cleavage of HK by plasma kallikrein results in kininogen heavy 
chain (63 kDa), light chain (58 kDa) and modified light chain (45 kDa). It has 
been reported that downregulation of plasma HK precedes the onset of 
preeclampsia (20-week gestation) (Blumenstein M, 2009). 
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In agreement with these observations, we found that the kininogen modified 
light chain (45 kDa) was down-regulated in UCS of IUGR newborns. Moreover, 
it has been reported that reduced levels of vasodilator substances, such as 
prostacyclin and kallikrein, may have a causal role in IUGR (Salas SP, 1993, 
Salas SP, 2007).  
1.5.4 Iron and copper homeostasis, oxidative stress and IUGR 
Copper and iron metabolism are known to be linked and to play a pivotal role 
during pregnancy: transferrin (Tf) is the main protein regulating Fe homeostasis, 
whereas ceruloplasmin (CP) is the major copper-carrying protein which acts as 
a circulating ferroxidase enzyme, able to oxidise ferrous ions to less toxic ferric 
forms. Together ceruloplasmin and transferrin act as an antioxidative system. 
Iron deficiency during pregnancy is common and has serious consequences 
both in the short and the long term such as foetal growth retardation and 
cardiovascular problems in the adult offspring. Similarly, Cu deficiency, although 
not so common, also has deleterious effects (Gambling L, 2003, Andersen HS, 
2007). Here we shown that serotransferrin was down-regulated in UCS, while 
ceruloplasmin was decreased in AF of IUGR newborns. 
Several studies have shown a link between altered iron homeostasis and 
growth retardation: a decrease in transferrin receptor 1 has been reported in 
IUGR placentas (Mando C, 2010); elevated maternal ferritin was related to an 
increased risk of IUGR (Soubasi V, 2010), while a decrease of serum 
concentrations of total and highly sialylated serotransferrins was detected in 
severe preeclampsia (Wu Y, 2003). In addition, concerning copper 
homeostasis, it has been demonstrated that in IUGR placentas the level of Cu 
was significantly reduced (Zadrozna M, 2009), and that ceruloplasmin levels 
were decreased in small for dates babies (Salimonu LS, 1992, Airede AI, 1998).  
 
1.6 Conclusion 
Our results support the conclusion that the IUGR condition alters the expression 
of proteins, some of which are involved in the coagulation process, immune 
mechanisms, blood pressure and iron and copper homeostasis control. The 
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identification of proteins, whose expression is altered by IUGR, may contribute 
to improve the understanding of this important clinical condition, leading to the 
individuation of candidate proteins that could be further investigated as 
biomarkers. The real importance of all of these candidates require further 
validation in vitro and in vivo; nevertheless, they could represent promising 
diagnostic targets, and shed a ray of hope for a target-oriented therapy of 
IUGR. 
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2  Chapter  
MOLECULARLY IMPRINTED POLYMERS  
FOR PHOSPHOPROTEOMICS 
 
2.1  Introduction 
The present project is aimed at developing a pre-fractionation approach for 
proteomics based on selective polymeric materials, to be used prior to 
proteome analysis for selecting classes of proteins on the basis on 
homogeneous functional criteria. 
2.2  A particular fraction of the proteome 
Post-translational modifications (PTMs) are processing events that change the 
properties of a protein by proteolytic cleavage or by addition of a modifying 
group to one or more amino acids. Far from being mere “decorations”, PTMs of 
a protein determine its activity state, localisation, turnover, and interactions with 
other proteins. In signalling, for example, kinase cascades are turned on and off 
by the reversibile addition and removal of phosphate groups, and in the cell 
cycle ubiquitination marks cyclins for destruction at defined time points (Mann 
M, 2003). 
Other examples of the biological effects of protein modifications are attachment 
of fatty acids for membrane anchoring and association, glycosylation for protein 
half-life, targeting, “cell-cell” and “cell-matrix” interactions. Consequently, the 
analysis of proteins and their PTMs is particularly important for the study of the 
physio-pathology (Baumann M, 2004). 
2.3 Phosphoproteomics 
2.3.1 Introduction 
Phosphorylation is the most widespread and studied Post Translational 
Modification (PTM) in proteins (Collins MO, 2007).  
It is involved in almost all cell functions: metabolism, osmoregulation, 
transcription, translation, cell cycle progression, cytoskeletal rearrangement, cell 
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movement, apoptosis, differentiation, regulation of the signal transduction 
pathways, intercellular communication during the development and functioning 
of the nervous system (Graves J, 1999, Hunter T, 2000, Sickmann A, 2001). 
The phosphorylation/dephosphorylation process is regulated by the switch 
kinases/phosphatases. Kinases add a phosphate group to a receptive side 
chain of an amino acid; phosphatases instead catalyse the hydrolysis of a 
phosphoester bond (Raggiaschi R, 2005, Thingholm TE, 2009). The effect of 
the addition or subtraction of a phosphate group is the modification of enzymatic 
activity, protein-protein interaction and cellular localisation. 
Phosphorylation is not a unique process: often a single protein can display more 
than a single site suitable for the process, often catalysed by different kinases. 
For example, glycogen synthase contains at least 9 phosphorylation sites, and 
its modulation is performed by at least 5 protein kinases acting on different sites 
of the protein (Nelson L, 2004). A misregulation of the phosphorylation 
processes can cause severe damage to the cells, leading to diseases such as 
cancer, diabetes or neurodegeneration (Clevenger CV, 2004, Zhu X, 2002). 
The most common kind of phosphorylation in eukaryotes is O-phosphorylation, 
on serine, threonine and tyrosine with a ratio of 1800/200/1 (Grønborg M, 2002, 
Kersten B, 2006). Other sites of phosphorylation can be histidine, lysine, 
arginine, glutamic acid, aspartic acid and cysteine (Sickmann A, 2001), even 
though these are less studied due to the lability of the chemical bonds involved 
and the subsequent necessity to use very special techniques to analyse them. 
It is estimated that 2-4% of eukaryotic genes are associated with kinases and 
phosphatases (there are about 500 kinase and 100 phosphatase genes in the 
human genome) (Manning G, 2002, Twyman RM, 2004, Venter JC, 2001). 
Around 100,000 phosphorylation sites may exist in the human proteome, the 
majority of which are presently unknown (Zhang H, 2002 ). The importance of 
studying phosphorylation was marked by the success of the cancer drug 
Gleevec, the first to inhibit a specific kinase, which gave definitely an impulse to 
the research on kinases and their substrates as potential drug targets (Manning 
G, 2002). 
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The comprehensive analysis of protein phosphorylation should include: 
identification of phosphorylated proteins and of their sites of phosphorylation, 
how these phosphorylations modify the biological activity of the protein and the 
identity of the kinases and phosphatases involved in the process.  
2.3.2 A delicate analysis 
Working in phosphoproteomics presents a series of hurdles in the analytical 
strategy.  
The first issue concerns the reversible nature of phosphorylation. The study of 
phosphoproteins necessitates their isolation from a cell extract or a sub-cellular 
compartment. Subsequently to cell lysis, however, many enzymes such as 
phosphatases become active, determining the degradation of the proteins and 
detachment of phosphate groups from their sites. Also kinases can express 
their action, confusing the picture of which phosphate groups are biologically 
relevant (Raggiaschi R, 2005). Working at low temperature helps significantly in 
slowing down these processes, but it’s not enough. In order to stop the action of 
these enzymes it is essential to add a specific mix of inhibitors of proteases and 
phosphatases to the cell extracts (Thingholm TE, 2008) while in order to inhibit 
kinases, EDTA, EGTA or kinase inhibitors are added. It is also important to 
choose an inhibition mix that does not interfere with downstream analytical 
methods, such as phospho-specific enrichment methods.  
Another issue relates to the characterisation of phosphoproteins which is mostly 
performed through Mass Spectrometric (MS) methods after enzymatic 
digestion. The detection of phosphopeptides (FPs from now on) with MS is 
hampered by the presence of their non-phosphorylated partners; moreover, the 
efficiency of ionisation is higher for the latter species, also generally more 
abundant in the sample (this fact is referred to as “low stoichiometry” of 
phosphorylation). 
It follows that enrichment methods are necessary to extract the 
phosphoproteins or the FPs from the sample. There are various methods to 
choose from, depending to the kind of sample and the aims of the study. 
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2.3.3 Detection of phosphoproteins 
The detection of phosphoproteins in a sample still relies on optimised “classical” 
methods.  
2.3.3.1 Isotopic labelling of phosphoproteins 
One of the oldest methods used to study phosphoproteins is metabolic labelling 
with 32P and 33P. This consists of nourishing living cells or organisms with 
substances labelled with these radioactive isotopes which are incorporated into 
the synthesised proteins. Following lysis of the cells, the protein population is 
isolated through 1-DE or 2-DE, visualised on the gels with autoradiography or 
acquired digitally with Phosphorimager systems. This method is still largely 
employed, because of its simplicity and reliability when working with “live” 
systems in vitro or in vivo (Eymann C, 2007). 
A comparison between the performances of 32P and 33P in labelling the proteins 
indicates that 33P gives neater images and higher resolution, even though a 
longer exposure time is required with, respect to 32P (Guy GR, 1994). 
Apart from the safety and environmental implications in using radioactive 
isotopes, this method has other drawbacks. First of all it is not compatible with 
some downstream methods, such as MS. Furthermore it can only be applied on 
viable cells, since the radioactive isotopes have to be taken from the media and 
metabolised: it cannot therefore be applied to post-mortem tissues or biopsies. 
In in vivo studies, cells are incubated with 32P, however the presence of ATP 
reservoirs within the cells can interfere with the labelling, reducing the efficiency 
of the method (Steen H, 2001). Furthermore, 32P is toxic to the cells, and over 
time can cause damage (Hu VW, 2001). 
In in vitro studies, proteins are incubated with specific kinases in the presence 
of [γ-32P]-ATP and, under specific conditions, the radioactive atom is 
incorporated into amino acid residues. Due to the unnatural presence of kinase 
with respect to the target protein, the phosphorylation of a different target 
frequently occurs instead of the natural one (promiscuity) (Graham ME, 2007). 
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2.3.3.2 Western Blotting employing phosphospecific antibodies 
Western blotting is a quite an old technique. It is based on the selective binding 
of an antibody to a protein, transferred from a 1D or 2D gel to a nitrocellulose or 
polyvinylidene difluoride (PVDF) membrane support and subsequently revealing 
the antibody-marked spot with some visual method (Magi B). The key role is 
played by the antibody, which should be specific for the protein epitope of 
interest: in this case epitopes are phosphoserine, phosphothreonine and 
phosphotyrosine. The selectivity and affinity characteristics of the antibody are 
of major importance, in order to perform specific recognition and limit false 
positives. While excellent anti-phosphotyrosine antibodies have been developed 
(e.g. (PY)20, (PY)100 and 4G10 hybridoma clones), better antibodies are still 
needed for phosphoserine and phosphothreonine. Antibodies generated against 
pSer and pThr, in fact, very often necessitate use of a consensus sequence 
flanking the phosphoamino acid; this might be due to the lower immunogenicity 
of pSer/pThr compared to pTyr (Schmidt SR, 2007). 
Grønborg et al. performed a test for specificity and reliability of anti-
phosphoserine and anti-phosphothreonine antibodies (Grønborg M, 2002). 
They made a large scale differential analysis of phosphorylated proteins, 
succeeding in identifying phosphorylation sites and FPs not identified with 
dedicated prediction software. The combination of high resolution 2-DE 
techniques and the Enhanced ChemiLuminescence (ECL) system give 
improved sensitivity to the method, i.e. intensification of around 1000 times of 
the light emitted from a spot (Kaufmann H, 2001). 
Although Western blotting is an efficient technique to reveal even small 
amounts of protein (10-10 mol), its use in quantitative analysis is limited by the 
variability of the amount of proteins that can be transferred to the membrane. 
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2.3.3.3 Direct staining of phosphoproteins 
The easiest way to detect phosphoproteins in a sample is the direct staining 
with a phosphospecific dye after a SDS-PAGE gel. Many attempts have been 
made during the 1970’s (Steinberg TH, 2003), but all these methods faced 
problems in terms of sensitivity and of non-specificity, e.g. the inability to 
discriminate between phosphorylated and non-phosphorylated proteins or to 
detect phosphotyrosine. Quite recently a novel fluorescent dye has been 
introduced: Pro-Q Diamond. This dye selectively binds to phosphoproteins 
requiring a very simple experimental protocol. The sensitivity of the stain 
depends on the number of phosphorylated residues of the proteins: the 
detection limit was 16 ng for pepsin (1 phosphorylated residue) and 2 ng for 
casein (8 phosphorylated residues) (Schulenberg B, 2003). Thus, the method is 
very useful for a preliminary screening, but still not sufficient for a 
comprehensive analysis of the phosphoproteome.  
The dye is also compatible with MS and with Multiplex Proteomics (MP), i.e. 
simultaneously detecting phosphoproteins and total proteins (e.g. these latter 
stained with SYPRO Ruby dye) on the same 2D gel. The combination of the two 
staining methods permits distinguishing poorly represented but highly 
phosphorylated proteins from highly represented but poorly phosphorylated 
ones, comparing the results from the two different colorations. 
2.3.3.4 Detection of phosphoproteins employing protein phosphatases 
The presence or absence of a phosphate group on a protein is enough to 
change its pI and subsequently its position in the first dimension of a 2D gel. 
That’s why, by employing a phosphatase enzyme, it is possible to modify the 
position of a protein spot on a map and thus determine its nature comparing the 
maps before and after the treatment. Software has been also developed that 
can predict the pI shift due to the addition/removal of a phosphate group, which 
can be of the order of 1-2 pH units (Kumar Y, 2004). As an example, Yamagata 
et al. exploited the specific enzymatic activity of k-phosphatase (kPPase) on 
phosphoserine, phosphothreonine, phosphotyrosine and phosphohistidine 
residues to identify novel phosphoproteins in cultured rat fibroblasts (Yamagata 
A, 2002). 
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The methods employing phosphatases, however, are not suitable for 
quantitative analysis, mainly because of the complexity of the analysis and the 
variable efficacy of the enzymatic action. 
2.3.4 Selective enrichment of phosphoproteins and FPs 
The identification of the PTM sites on a protein is generally performed by using 
MS approaches. On most occasions, the only enrichment of the sample in 
phosphoproteins followed by protease-specific digestion and MS analysis is not 
sufficient to identify the sites of phosphorylation present (due to the general low 
stoichiometry of the phosphorylation), thus a second enrichment step at the FP 
level is often also required.  
Some commercial kits for phosphoprotein and FP enrichment are available, 
offering ease of use and reproducibility; nevertheless it has been clearly 
demonstrated that the methods available differ in the specificity of isolation and 
in the set of phosphoproteins and FPs isolated (Bodenmiller B, 2007), strongly 
suggesting that no single method is sufficient for a comprehensive 
phosphoproteome analysis. Strategies for phospho-specific enrichment are 
shown in Fig. 2-1.  
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Fig. 2-1. Selective enrichment of phosphoproteins and phosphopeptides.  
A) Immunoprecipitation: phosphoproteins or phosphopeptides are selectively 
precipitated through the use of appropriate anti-phospho antibodies; at the 
moment only the use of anti-pTyr antibodies has proven to be robust.  
B) Affinity chromatography: a resin with immobilised chelated metal or TiO2 can 
selectively bind the phosphoric group of peptides and also proteins in IMAC 
(Par. 2.3.4.2). A combined approach is SIMAC (IMAC + TiO2). An alternative 
technique could be the use of Molecularly Imprinted Polymers (MIPs, Par. 
2.3.4.10).  
C) Chemical derivatisation: the phosphoric group reacts with the aminogroup of 
a tag in PAC or can be subjected to β-elimination and linking of a suitable tag 
through Michael addition (Par. 2.3.4.11).  
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2.3.4.1 Phosphoprotein enrichment by immunoprecipitation 
Phospho-specific antibodies can be used to selectively immunoprecipitate 
phosphorylated proteins depending on the specificity of the antibody. As for 
Western blotting (see above) anti-phosphotyrosine antibodies are the most 
reliably and widely used in order to enrich tyrosine-phosphorylated proteins 
from complex mixtures. 
After immunoprecipitation (IP) the phosphotyrosine enriched sample can be 
analysed with different analytical methods such as 1-DE and 2-DE (Stannard C, 
2003).  
Also in this case, variations of protein phosphorylation levels are very difficult to 
characterise except in combination with a particular protein labelling (Stable 
Isotope Labelling with Amino acids in Cell culture: SILAC, see Par. 2.3.6.1) 
using stable isotopes (13C or 15N) is used (Ong SE, 2002). This strategy allowed 
a quantitative and temporal investigation of tyrosine phosphorylation events of 
proteins involved in signalling pathways after stimulation with Epidermal Growth 
Factor (EGF) (Blagoev B, 2004). 
2.3.4.2 Phosphopeptide and phosphoprotein enrichment using 
Immobilised Metal Affinity Chromatography (IMAC) 
IMAC exploits the material formed through chelation of a di-, tri- or tetravalent 
metal by nitrilotriacetic acid (NTA), iminodiacetic acid (IDA) or 
Tris(carboxymethyl)ethylenediamine (TED) immobilised on a solid support, such 
as porous silica beads (Porath J, 1975). The most commonly used resins make 
use of Fe3+, Ga3+ and Al3+, even though Zn2+ and Zr4+ are used as well (Feng S, 
2007). 
This method is employed by routine in the enrichment of FPs prior to MS 
analysis, nevertheless it has some limititations; the most evident of which is its 
undesirable ability to bind acidic peptides. This limitation has been largely 
surpassed by the acidification of the medium (to protonate the carboxylic 
groups) (Posewitz MC, 1999) and esterification of the carboxylic moieties with 
methanolic HCl before the enrichment step, even if this method introduces 
complexity due to the variable yield of methylation. 
A second limitation is the net bias of the method towards multiply 
phosphorylated peptides (Ficarro SB, 2002). 
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The method is particularly effective when used in combination with an 
enrichment step at the protein level. This operation can be carried out with 
methods such as IMAC itself, exploiting however a more suitable solid support, 
such as sepharose beads. Moreover, secondary interactions have to be 
reduced, e.g. with the use of denaturing conditions (6M urea). The detachment 
of the potentially many phosphate groups from the column imposes instead the 
use of a strong eluting buffer such as 0.1-0.2 M EDTA (Collins MO, 2005). 
Other phosphoprotein enrichment methods are phosphotyrosine IP (Ficarro S, 
2003), Strong Anion eXchange chromatography (SAX) (Trinidad JC, 2006), 
Strong Cation eXchange chromatography (SCX) (Nühse TS, 2003) and SDS-
PAGE (Villen J, 2007). 
2.3.4.3 Metal Oxide Affinity Chromatography (MOAC) 
Metal oxide chromatography (MOAC) employs mainly Ti, Zr or Al oxides, in the 
form of solid or coated beads, as chromatographic media to sequestrate FPs. 
Many different crystalline forms and nanostructured materials have been 
devised (Leitner A, 2010). 
The first report concerning the potential of these materials regarded the use of 
TiO2-based columns to sequestrate phosphate ions from water (Ikeguchi Y, 
2000).  
In 2004, Pinkse et al. published a paper on the use of this material to bind FPs. 
They devised a 2D-LC-MS online strategy with TiO2 beads (Titansphere) as the 
first dimension and RP as the second.  
Acidic conditions (pH 2.9) promoted the adhesion of FPs to the first column, 
leaving the non-phosphorylated peptides to flow through and be analysed with 
nano-LC-RP- MS/MS. Basic conditions (pH 9.0) were used to elute FPs in a 
second step. The method was tested on a 153kDa homo-dimeric cGMP-
dependent kinase, promoting the discovery a total of 8 phospho-sites, 2 of 
which were novel. 
Larsen’s group then devised an off-line strategy to bind FPs to a TiO2 material. 
The use of additives such as 2,5-dihydroxybenzoic acid (DHB), phthalic acid or 
glycolic acid largely reduced the non-specific attachment of acidic peptides 
 36 
(Jensen SS, 2007). This technique has been named HAMMOC, for hydroxy 
acid modified metal oxide chromatography. 
A significant advantage of TiO2 is its tolerance towards most buffers and salts 
used in biochemistry and cell biology laboratories. This is one of the reasons 
which made TiO2 so common in large scale phosphoproteomics studies (Olsen 
JV, 2007). Not only has titanium oxide been employed for FPs enrichment. ZrO2 
microtips have recently been introduced as mean of FPs enrichment. This oxide 
shows a better performance in enriching singly phosphorylated FPs with respect 
to TiO2 (Kweon HK, 2006). However, subsequent large-scale studies have also 
demonstrated a lower selectivity with regard to acidic peptides (Sugiyama N, 
2008), suggesting the necessity for further improvements. 
2.3.4.4 Sequential elution from IMAC (SIMAC) 
The identification of multiply phosphorylated peptides has proven to be a hard 
task, mostly because of their difficult ionisation and subsequent low signal 
compared to singly- and non-FPs, so as to be not selected for subsequent 
fragmentation in the mass spectrometer.  
To address this issue, in 2007 Martin Larsen’s group presented an analytical 
strategy for sequential elution of mono- and multi-phosphorylated peptides. The 
sequential elution from IMAC (SIMAC) exploits the complementary 
characteristics of IMAC and TiO2 in enriching the sample respectively in multiply 
and singly phosphorylated peptides (Thingholm TE, 2008). 
In particular, the elution from IMAC in acidic conditions (pH 1.0) enriches the 
sample in mono-FPs, while the basic conditions (pH 11.3) elute subsequently 
the multi-FPs (Thingholm TE, 2008) A further enrichment with TiO2 
chromatography is needed only in the acidic fraction, because the basic one is 
sufficiently depleted of non-FPs. 
The separation of singly and multiply FPs permits their analysis with pdMS3 
(phosphorylated directed fragmentation) in optimised settings for each group 
(Thingholm TE, 2008). This method was tested on a 120 µg whole-cell extract 
from human mesenchimal stem cells (hMSCs) and the results compared with 
those from TiO2 enrichment alone. A total of 716 phospho-sites were identified 
with SIMAC, while the number was 350 with TiO2. Moreover the number of 
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multiply phosphorylated peptides was also significantly increased (Thingholm 
TE, 2008).  
Recently, an intriguing new method for the enrichment of multiply 
phosphorylated peptides, based on polyarginine-coated diamond nanoparticles 
was presented, however it has still to be tested on large scale samples and 
where a low amount of starting material (micrograms) is available (Chang Ck, 
2008). 
2.3.4.5 Magnetic beads 
Starting from the TiO2-based chemistry and with the idea of finding an easier 
way to perform the extraction of FPs, Chen and Chen (Chen CT, 2005) thought 
to conjugate the properties of magnetic materials with those of TiO2, by coating 
Fe3O4 nanoparticles with TiO2 through a silane bridge. The nanobeads were 
mixed with a tryptic digest, vortexed and captured with a magnet. The captured 
FPs were subsequently analysed through a laser desorption/ionisation from the 
inorganic particles and a run in MS. The method was named SALDI-MS, from 
Surface Assisted Laser Desorption/Ionisation Mass Spectrometry (Schürenberg 
M, 1999). There were subsequent improvements of the method, using for 
example Fe3O4@C@SnO2 core-shell microspheres (the symbol @ means 
“coated by”), with which scientists were able to detect 77 phosphorylation sites 
in rat liver cells (Qi D, 2009). 
2.3.4.6 Calcium phosphate precipitation (CPP) 
In 1994, Reynolds et al. presented a strategy for FPs enrichment through Ca2+ 
ions and 50% ethanol precipitation. The precipitated peptides from a tryptic 
digest of casein mostly contained multiple phosphoserines (Reynolds EC, 
1994). 
Zhang et al. tested the strategy by using calcium chloride (CaCl2), ammonia 
solution (NH3·H2O) and disodium phosphate (Na2HPO4) on a rice embryo 
preparation (Zhang X, 2007). The dissolved and desalted pellet was then 
enriched through IMAC. In total, 227 non-redundant phosphorylation sites were 
identified, of which 213 were on serine residues and 14 on threonine.  
Through phosphate precipitation directly coupled to LC-MS/MS, Qiangwei Xia et 
al. identified 466 unique phosphorylation sites (379 on serine and 87 on 
 38 
threonine) in post-mortem Alzheimer’s disease brain tissue, 70% of which were 
not reported in the Phospho.ELM database (Xia QW, 2008). 
In both studies no tyrosine phosphorylated peptides were identified: it is not 
clear if this is due to the low abundance of these residues or to the poor 
selectivity of the method. Anyway the method offers the advantage of being 
rather simple, column-free and straightforward. 
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Tab. 2-1. Comparison of enrichment and fractionation methods for 
phosphopeptides. 
M
e
th
o
d
 
T
a
rg
e
t 
S
a
m
p
le
 t
y
p
e
 
a
n
d
 a
m
o
u
n
t 
 
S
tr
a
te
g
y
 
R
e
s
u
lt
s
 
R
e
fe
re
n
c
e
 
C
o
m
m
e
n
ts
 
IMAC 
(Immobilised 
Metal Affinity 
Chromatography) 
IDA or NTA on a 
polymer matrix or 
magnetic beads 
with chelated Fe
3+
, 
Ga 
3+
, Al
3+
 or other 
metal cations. 
Binding through 
electrostatic 
interaction between 
phosphate  groups 
and metal cations. 
 protein,  
 peptide 
H1 stem cells 
proteins, 10 mg 
 
SCX- 
IMAC- 
RPLC- 
MS
2
  
(ETD-OT)  
10844 
phosphosites at 
1% FDR  
 
(Swinkels D, 
2008) 
Proven to be 
effective in 
large scale 
analysis.  
Limited 
capacity and 
specificity, 
directed 
towards 
multiply 
phosphorylat
ed peptides, 
affinity for 
acidic 
peptides 
 
 D.melanogaster 
lysate  
 Kc167,10 mg 
SCX- 
IMAC- 
RPLC- 
MS
2
  
(LTQ-OT) 
13720 
phosphosites at 
0.63% FDR 
(Zhai B, 
2008) 
MOAC  
(Metal Oxide 
Affinity 
Chromatography) 
TiO2, ZrO2 or 
Nb2O5 as particles 
or layered on a 
Fe3O4 magnetic 
core. Bidentate 
binding between  
metal and 
phosphoric group 
oxygens. 
peptide HeLa lysate 
(amount not 
given) 
 
SCX- 
TiO2- 
RP- 
MS
2
 &MS
3
 
(LIT-FT-
ICR) 
6600 
phosphosites, 
2244 proteins 
at<1%FPR  
 
 
(Olsen JV, 
2006) 
 
Robust and 
chemically 
inert 
material, 
high capacity 
and fast 
absorption. 
Slow flow 
desorption, 
most 
effective for 
singly 
phosphorylat
ed peptides. 
 K562 lysate, 400 
µg 
 
SCX-
TiO2/Nb2O5
-RP- 
MS
2
  
(MALDI-
TOF) 
622/642/834 
phosphopeptides 
(Ti/Nb/all*) at 
4%FPR 
(Ficarro S, 
2008) 
 
SCX (Strong 
Cation Exchange) 
Ion Exchange 
Chromatography. 
Phosphopeptides 
less retained by 
stationary phase 
due to their higher 
negative charge 
peptide HeLa cell lysate,  
300 µg 
 
SCX- 
RP-  
LC- 
MS
2
&MS
3
 
(IT) 
2002 
phosphosites 
 
(Beausoleil 
SA, 2004) 
Coelution 
with other 
acidic 
peptides. 
Useful as 
pre-
enrichment 
technique 
 HEK 293 cell  
lysate, 1 mg 
SCX- 
RP- 
LC- 
MS
2
 
(ETD,LIT) 
>5000 unique 
phosphopeptides 
1%FDR 
(Mohammed 
S, 2011) 
 
continue… 
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SAX (Strong 
Anion Exchange) 
Ion Exchange 
Chromatography. 
Phosphopeptides 
more retained by 
stationary phase 
due to their higher 
negative charge 
peptide Human liver 
protein digest,  
100 µg 
SAX- 
RPLC- 
MS2&MS3 
(LTQ) 
274 
Phosphosites at 
0.96% FDR 
 
(Han G, 
2008) 
Useful for 
peptide 
fractionation. 
Useful as pre-
enrichment 
technique 
 A.thaliana 
membrane 
proteins 
digest, 500 µg 
SAX- 
IMAC- 
RPLC- 
MS
2
  
(Q-TOF) 
299 
Phosphopeptides 
(Nühse TS, 
2003) 
HILIC (Hydrophilic 
Interaction 
Chromatography) 
Phosphopeptides 
more retained by 
stationary phase 
due to their higher 
polarity 
peptide HeLa cell 
lysate, 1 mg 
 
HILIC- 
RP- 
MS & S2 
(IT) 
1004 
phosphosites 
  
(McNulty DE, 
2008) 
 
Coelution with 
other acidic 
peptides. 
Useful as pre-
enrichment 
technique 
 S.cerevisiae 
total protein,  
6 mg 
IMAC- 
HILIC- 
RP- 
HPLC- 
MS
2
  
(LTQ) 
8764 unique 
phosphopeptides,  
2278 proteins 
(Albuquerque 
CP, 2008) 
 
*superimposition without redundancies of Ti and Zr detected phosphosites. 
Abbreviations: CID, Collision-Induced Dissociation; DHB, Dihydroxybenzoic 
acid; ECD, Electron Capture Dissociation; ETD, Electron Transfer Dissociation; 
FDR, False Discovery Rate; FPR, False positive rate; FT-ICR, Fourier Transform 
Ion Cyclotron Resonance; b-HPA, b-hydroxypropanoic acid; LIT, Linear Ion Trap; 
OT, Orbitrap; Q-TOF, Quadrupole-Time-Of-Flight; RP, Reversed Phase; SCX, 
Strong Cation Exchange; LTQ, Linear Trap Quadrupole; LCQ, Liquid 
Chromatography Quadrupole; IP, Immunoaffinity Purification. 
 
2.3.4.7 Ion exchange chromatography (IC) 
The simple enrichment of FPs with IMAC, TiO2 or SIMAC has generally proven 
to be not productive when a deep knowledge of the phosphoproteome is 
required (Rigbolt KT, 2011).  
A fractionation step is also needed. Chromatography techniques based on 
charge interaction, hydrophilic interaction or a combination of both has been 
employed for this purpose (Zarei M, 2011). 
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Anion exchange chromatography exploits the generally higher affinity of FPs for 
the positively charged stationary phase due to the intrinsic high negative charge 
carried by the phosphate group. Strong anion chromatography (SAX) has been 
employed both as a fractionating technique before a FPs enrichment step (e.g. 
with IMAC or TiO2) (Zhang K, 2006) and also as sole fractionating technique 
before LC-MS/MS.  
Nühse et al. for example identified more than 300 phosphorylation sites in the 
plasma membrane fractions of Arabidopsis thaliana using a SAX + IMAC 
approach (Nühse TS, 2004), while Han and co-workers identified 274 
phosphorylation sites in human liver tissue extract without the enrichment step. 
A drawback of this method has been reported by Thingholm et al. (Thingholm 
TE, 2009), who noted a strong attachment of FPs to the SAX resin, from which 
they are recovered with difficulty. 
Its counterpart, strong cation chromatography (SCX), has been largely 
employed as a prefractionating technique for proteins and peptides. The 
pioneering work on FPs was carried out by Beausoleil et al. in 2004 (Beausoleil 
SA, 2004). Tryptic peptides were acidified at pH 2.7, where most of the peptides 
carry a +2 charge due to C-terminal lysine or arginine and the N-terminal amino 
group. FPs, instead, carry a reduced charge due to the phosphate group, e.g. 
+1 in monoFPs. The reduced affinity of the resin should therefore allow FPs to 
flow more easily through the column. This idea was confirmed by the results, 
which brought about the identification of 2000 phospho-sites in 8mg of nuclear 
extract of HeLa cells lysate. 
Trinidad and co-workers evaluated the efficiency of SCX as a prefractionation 
method prior to IMAC compared to the efficiency of IMAC and SCX alone, 
finding a three-fold increase in FPs identified in the combined approach with 
respect to either single method (Trinidad JC, 2006). 
The strength of SCX as a prefractionating system was further confirmed by 
Olsen et al., who identified 6600 phospho-sites in 2244 proteins in EGF-
stimulated HeLa cells through SCX + TiO2 (Olsen JV, 2006). In more recent 
reports 23000 and 36000 phosphorylation sites have been identified 
respectively with SCX followed by IMAC and TiO2 respectively (Huttlin EL, 
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2010, Rigbolt KT, 2011). This remarkable increase in number of detected 
phospho-sites is mainly due to instrumental and software improvements (Zarei 
M, 2011). 
It remains to be assessed whether the fractionation/enrichment approach can 
be suitable in samples where a small amount of starting material is available. 
2.3.4.8 Hydrophilic Interaction Chromatography  
Hydrophilic interaction chromatography (HILIC) is a separation technique for 
biomolecules (Alpert AJ, 1990). The method relies on the interaction of the 
analytes, e.g. peptides, with a neutral stationary phase through hydrogen 
bonding. They are eluted from the column with a mobile phase gradient, 
decreasing in organic content, according to their polarities (hydrophilicity).  
McNulty and Annan introduced this method as a prefractionation step before 
IMAC (McNulty DE, 2008). They tested the FPs enrichment capacity of HILIC 
compared to SCX and IMAC alone, as well as the fractionation ability of HILIC 
before and after IMAC treatment. The analysis of 1 mg of tryptic digest of HeLa 
cells demonstrated the prefractionation ability of the method. The use of IMAC 
prior to HILIC in fact gave a high level of nonspecific binding due to non-FPs, 
while the reversed approach improved the selectivity towards FPs to more than 
99%. 
ERLIC (Electrostatic Repulsion - Hydrophilic Interaction Chromatography), or 
Ion Pair normal phase, is a newly developed chromatographic method able to 
enrich and fractionate FPs in a single step (Alpert AJ, 2008).  
At pH 2.0 the C-termini and the carboxylic side chains of Asp and Glu are 
neutral, thus the peptides are generally positively charged and are not retained 
by a positively charged stationary phase. The presence of a phosphate group, 
however, reduces the net charge of FPs. This is not enough to overcome the 
overall repulsion for the stationary phase due to the basic residues, however an 
organic mobile phase, e.g. acetonitrile 70%, promotes their hydrophilic 
interaction within the column. The attraction for the column is enhanced in 
multiply phosphorylated peptides.  
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Zarei et al. showed a higher efficiency of ERLIC compared to SCX and HILIC in 
the fractionation of multiply phosphorylated peptides (Zarei M, 2011) more 
strongly retained by the stationary phase. 
In a recent article (Chen X, 2011) Xi Chen et al. compared the FPs profiles 
obtained from a HeLa cell lysate by using 4 HPLC methods after a phosphor-
enrichment with IMAC. Even though with any of the four methods (SCX, HILIC, 
ERLIC with volatile and non-volatile solvents) 4-5000 peptides could be 
identified, the combination of all the methods gave a total number of 9069 
unique FPs, with a considerable amount of non-overlapping unique FPs. The 
four methods are thus complementary to fully cover the phosphoproteome.  
2.3.4.9 Hydroxyapathite (HAP) 
Firstly introduced by Tiselius and co-workers in 1956 (Tiselius A, 1956), 
hydroxyapathite (HAP) chromatography has been very popular until the 1980s, 
when new matrices were introduced. HAP is a crystalline form of calcium 
phosphate with the formula Ca10(PO4)6(OH)2, which binds FPs by virtue of both 
anionic and cationic interactions. In particular, Ca2+ binds phosphoric groups, 
and more strongly than it does other acidic groups. Binding to the matrix is thus 
proportional to the number of phosphor-groups on the peptides and can be 
exploited for their sequential elution according to their degree of 
phosphorylation. Mamone et al. (Mamone G, 2010) exploited this material to 
analyse a tryptic digest of standard proteins. The advantages of HAP are the 
low cost of the material and the possibility to elute stepwise the peptides 
according to the degree of phosphorylation. Yet the system has to be tested on 
more complex biological samples. 
 
2.3.4.10 Molecularly Imprinted Polymers (MIPs) 
Recently (Helling S, 2011), Sellergren’s group has proposed a method for the 
depletion of phosphotyrosine containing peptides based on Molecularly 
Imprinted Polymers (MIPs). FP imprinting was performed using an epitope 
approach (Nishino H, 2006), i.e. using a part of the analyte of interest (in this 
case the N- and C-protected phosphotyrosine) as template to prepare a MIP 
able to fish for FPs. The Solid Phase Extraction analysis showed an 18-fold 
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preferential retention for phosphorylated angiotensin II with respect to the non-
phosphorylated peptide, a preference not shown by the non-imprinted polymer. 
Moreover, the material showed a preference for a triply phosphorylated peptide 
over a monophosphorylated one, showing opposite behaviour comparing to 
TiO2 material. Of course a more extensive analysis and improvements are 
needed in order to tackle more complex samples.  
2.3.4.11 Chemical derivatisation strategies 
Chemical derivatisation strategies exploit the typical properties of phosphate 
groups on peptides, such as the lability of the phosphoester bond and the 
subsequent easy substitution of phosphate with a nucleophilic tag.  
A different widely used approach is the methyl esterification of the carboxylic 
groups, notoriously competitive with the phosphate groups due to their negative 
charge (Fig. 2-2).  
2.3.4.11.1 Methyl esterification of carboxyl-groups  
In the IMAC strategy carboxylic groups influence the elution of FPs, due to their 
charge being attracted by the positively charged metal of the resin. For this 
reason their esterification could prove useful. Ficarro et al. first applied this 
strategy for the analysis of the cell extract from Saccharomyces cerevisiae 
(Ficarro SB, 2002) through the IMAC approach: 383 sites of phosphorylation 
were detected with this method. Some characteristics of this approach have 
already been depicted in Par. 2.3.4.2 and not will be further analysed. 
Methyl esterification can be also exploited as a mean of isotopic labelling (with 
CH3OH and CD3OH for two different cellular states) for quantification purposes 
(Ficarro S, 2003). 
 
2.3.4.11.2 Biotin tagging by β-elimination and Michael addition 
Many chemical derivatisation strategies have been devised to displace the 
phosphoryl group and bind a tag to the “naked” peptide. One of these methods 
(Jaffe H, 1998) relies on the β-elimination of the phosphate from phosphoserine 
and phosphothreonine producing dehydroanaline and β-aminobutyric acid 
respectively. These products can be directly detected using tandem MS or 
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derivatised, for example by Michael addition of a reactive thiol and subsequent 
binding of a tag. 
One common tag is biotin, notoriously having great affinity for avidin, ideal for 
immobilisation to an affinity column (Oda Y, 2001).  
This technique shows the limits of not being applicable to phosphotyrosine 
containing peptides and of the occurrence of side reactions such as tagging of 
non-phosphorylated serines. 
Zhou et al. (Zhou H, 2001) proposed another method of derivatisation 
applicable to all residues, even if it involves many steps and has not been 
tested on complex samples yet.  
 
 
Fig. 2-2. Chemical derivatisation methods for phosphorylation capture and 
analysis.  
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A) IMAC suffers of not specific binding of acidic peptides to the resin. 
Esterification of carboxylic groups with Methanol/HCl is a strategy to overcome 
this problem. 
B) In presence of a strong base the β-elimination at phosphoserine and 
phosphothreonine produces dehydroanaline and  β-aminobutyric acid. These 
can be derivatised with a thiol through a Michael-like addition and a tag can be 
added. If the tag is biotin, its affinity with avidin can be exploited. 
C) FPs can be derivatised to phosphoramidates after esterification of carboxylic 
groups. If a dendrimer is employed the derivatised peptides can be separated 
through size-selective methods. 
D) β-elimination and Michael-like addition of cysteamine converts phosphoserine 
and phosphothreonine in lysine  analogues that specific enzymes leave in the C-
terminus. 
 
2.3.4.11.3 Phosphoramidate conversion 
In 2005 Aebersold’s group proposed a derivatisation procedure based on the 
carboxyl protection through methyl esterification followed by conjugation to a 
soluble polymer with phosphoramidate chemistry (PAC) (Tao WA, 2005). 
The mixture of peptides is first converted to the corresponding methyl esters. In 
this step two cellular states can also be differentially labelled for quantitative 
analysis. Subsequently, the methylated peptides are combined and allowed to 
react with EDC, imidazole and a polyamine dendrimer. Phosphopeptides are 
converted into the corresponding phosphoramidates, easily separated from the 
non-FPs through size selective methods. FPs are recovered with a brief acid 
hydrolysis and sent to MS analysis. 
When coupled with pervanadate stimulation and an initial antiphosphotyrosine 
protein precipitation step, this method allowed the identification and 
quantification of all known, plus previously unknown phosphorylation sites in 97 
tyrosine proteins in Jurkat T cells. 
A modification of this method was proposed (Bodenmiller B, 2007), exploiting 
the reaction of the phosphate groups with cystamine and a reducing agent 
instead of the dendrimer. The –SH group of cystamine react with maleimide-
activated glass beads, immobilizing the FPs on a solid phase. This method 
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allowed the identification of 229 FPs in the cytosolic proteome of Drosophila 
melanogaster Kc167 cells without any pre-enrichment step. 
2.3.4.11.4 Conversion to aminoethylcysteine 
Even after a good preconcentration step it is difficult to exactly assign a 
phosphorylation site, due to the lability of the phosphate group, often lost during 
the backbone fragmentation in a MS collision, and to the intrinsic low 
abundance of phosphorylated peptides. 
To address this problem, Knight et al. (Knight ZA, 2003) devised a derivatisation 
method based on β-elimination and Michael addition of cysteamine to convert 
phosphoserine and phosphothreonine into aminoethylcysteine (Aec) and β-
methylaminoethylcysteine respectively. Due to the resemblance of Aec to 
lysine, the use of proteases that recognise this amino acid (e.g. Lys-C and lysyl 
endopeptidase) cleaves proteins leaving it at the C-terminus. The system works 
also with β-methylaminoethylcysteine and permits the identification of the exact 
site of phosphorylation.  
The limitation of the method is racemisation in the addition step, converting only 
50% of the phosphoamino acids in the appropriate enzyme substrate. In the 
case of multiply phosphorylated peptides this fact greatly increases the 
complexity of the peptidic mix arising from the protein.  
2.3.4.12 Comparison of enrichment methods 
From this survey of enrichment methods it is evident that no single technique is 
able to tackle the entire phosphoproteome. Some methods work in the direction 
of enriching only some species, such as the antibodies for phosphotyrosine or 
the combination β-elimination/ Michael addition selective for phosphoserine and 
phosphothreonine. Other methods, such as calcium precipitation, SAX, SCX 
and HILIC, work better as pre-separation techniques to reduce sample 
complexity before more specific enrichment methods such as IMAC, MOAC, 
SIMAC and PAC.  
Every enrichment technique presents advantages and disadvantages, but also 
different specificities. Usually, MOAC is more specific for monophosphorylated 
peptides, due to the strong affinity for multiply phosphorylated ones, and their 
lack of elution. On the contrary, IMAC is more specific for multiply 
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phosphorylated peptides, but has a lower capacity and selectivity when used 
with highly complex samples. The combined approaches, such as SIMAC, 
seem to be promising but reveal the necessity of a pre-enrichment step (Han G, 
2008). 
A systematic comparison of methods was made by Bodenmiller and co-workers 
(Fig. 2-3). They examined the reproducibility, specificity and efficiency of IMAC, 
PAC and two protocols for TiO2 chromatography: pTiO2 (phthalic acid in the 
loading buffer to quench nonspecific binding) and dhbTiO2 (2,5-dihydrobenzoic 
acid, quencher too) (Bodenmiller B, 2007). Each method was tested through the 
injection of 1.5 mg of tryptic digest from cytosolic fractions from Drosophila 
melanogaster cells. The authors found very good reproducibility for all the 
methods, making them suitable for quantitative analysis. Moreover, none of the 
methods was able to reveal the entire phosphoproteome, but they showed 
partially overlapping results between each other. 
In general a simple and straightforward strategy is desired, with few preparation 
steps and little sample handling in order to avoid loss of FPs. It is of course true 
that the amount of starting material and the expertise of the people performing 
the extractions are also critical factors. For this reason detailed protocols are 
needed (Goto H, 2007, Thingholm TE, 2009). 
 
 
Fig. 2-3. Comparison of phosphorylation enrichment methods. The graph shows 
the efficiency and selectivity of IMAC, PAC and TiO2, applied on a tryptic digest 
of a cytosolic protein extract of D. melanogaster cells (Bodenmiller B, 2007). In 
the starting material no FPs were detected, while the best selectivity in terms of 
P vs. not-P sites was IMAC. 
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2.3.5 MS-based strategies for phosphoproteome analysis 
Mass spectrometry has become the preferential method for peptide and protein 
identification following the separation steps, also in the PTM analysis (Domon 
RB, 2006).  
The first step of a typical MS analysis consists of the cleavage of a single 
protein or a protein mixture by a dedicated enzyme, usually trypsin, which 
preferentially cleaves the peptide bonds after arginine or lysine. Moreover, the 
tryptic fragments’ weights are in the range 700-3500 Da, a size suitable for MS 
analysis.  
The peptides are thus separated by nanoLC and vaporised/ionised through an 
ESI source. Their mass is evaluated and a second fragmentation, generating 
MS/MS spectra, permits to evaluate also their amino acid sequence. This is 
possible because of the higher lability of the bonds between amino acids. 
Depending on the position of the cleavage along the peptide chain, the MS/MS 
fragments are classified in a,b,c (starting from the N-terminal) or x,y,z (starting 
from the C-terminal) according to Roepstorff and Fohlman (Biemann K, 1988, 
Roepstorff P, 1984) (Fig. 2-4). Only the highest abundance peptides are 
submitted to MS/MS. This creates a hurdle in phosphoproteomics, because of 
the lower abundance and difficult ionisation of FPs compared to the co-present 
non-FPs, thus introducing the need for an enrichment step, as explained in Par. 
2.3.4. 
The information about the peptide sequence is submitted to database-digging 
software such as MASCOT (Perkins DN, 1999) or SEQUEST (Ducret A, 1998), 
which explore protein databases to find a sequence match with previously 
annotated proteins and rank the correlations through a probability score. 
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Fig. 2-4. Common nomenclature of peptide fragment ions. The peptide 
fragmentation in MS/MS mostly breaks the inter-residue bonds to generate 
fragment series. CID generates preferentially y and b ions, while mostly z and c 
ions are originated by ECD and ETD. Phosphotyrosine immonium ion is 
diagnostic of tyrosine phosphorylation.  
2.3.5.1 Collision Induced Dissociation (CID) 
The most established method to induce a secondary fragmentation in peptides 
is the collision induced dissociation (CID). Basically, the peptide ion collides 
with an atom of an inert gas (He or Ar) which transfers its kinetic energy, 
subsequently redistributed between the atoms bringing about the breaking of 
bonds. When a phosphoserine or phosphothreonine is present in the peptide 
sequence, the phosphoester bond is by far the most labile, thus a neutral loss of 
phosphoric acid H3PO4 (98 Da) takes place, generating dehydroalanine or 
dehydroaminobutiric acid respectively. Given that most of the energy is 
employed to break the phosphoester bond, far less energy is available for the 
subsequent fragmentation of the peptide chain (Larsen MR, 2005).  
This drains information when the identification of the phosphate group position 
is needed: only the bare presence or absence of a phosphate is assessed.  
To overcome this issue several strategies have been applied. The first one is 
the introduction of a tertiary fragmentation, specifically directed towards 
peptides where the loss of phosphate is detected. This strategy is named 
pdMS3 (phosphorylation directed MS3) (Reinders J, 2005). The information due 
to the alternative fragmentations of the precursor ion are lost in this case, but 
they can be retained through another approach, named Multi-Stage Activation 
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(MSA) (Steen H, 2001). In this case the ion trap, filled with the selected ion 
coming from neutral loss, is filled again with the original peptide and both are 
fragmented at the same time, giving rise to a more information-rich 
superimposed MS2 / MS3 spectrum.  
Partial neutral loss also happens at phosphotyrosine residues, which lose a 
HPO3 group (80Da) resulting in a characteristic phosphotyrosine immonium ion 
at m/z 216 (Fig. 2-4). The phosphoester bond is however more stable in this 
case, thus the information collection is not compromised. Steen et al., for 
example, used the diagnostic fragment at m/z 216 for the selective detection of 
phosphotyrosine-containing peptides in chicken ovalbumin and murine MAP-
kinase 2 (Steen H, 2001). 
2.3.5.2 Electron capture dissociation (ECD) 
The limitation of poor fragmentation of the peptide backbone in the presence of 
a phosphate group was overcome in 1998 with by the use of a new 
fragmentation strategy. Electron Capture Dissociation (ECD) is a method 
developed by Zubarev and colleagues to improve the fragmentation of multiply 
charged protein and peptide ions (Zubarev RA, 1998). These ions readily 
capture a thermal electron (<0.2 eV), which induces a non-ergodic 
fragmentation, i.e. without vibrational energy redistribution such as in CID. The 
result is fragmentation occurring mostly at S-S and N-Cα backbone bonds, 
leaving the PTM bonds intact. The generated ions are c and z type (Fig. 2-4) 
(Kleinnijenhuis AJ, 2007). The method has some drawbacks, such as a greater 
affinity for disulphide bonds and difficult fragmentation of N-terminal proline 
residues, which have two bonds to break. Moreover it can only be carried only 
with expensive FT-ICR instruments (costing around 1$ million) to generate the 
static magnetic field for the electrons, which reduces the wide-scale adoption of 
the technique. 
2.3.5.3 Electron transfer dissociation (ETD) 
The effort to find an ECD-like method without the need for expensive 
instruments brought about the advent of ETD (Electron Transfer Dissociation). 
In this approach the electron is transferred to multiply charged peptides (charge 
>2+) through a radical anion with low electron affinity, such as anthracene or 
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azobenzene (Schroeder MJ, 2005). The method can be implemented on linear 
quadrupole ITs, with their inherent drawbacks of reduced resolution and 
accuracy (Syka JE, 2004). Molina et al. (Molina H, 2007) carried out a large 
scale analysis of human embryonic kidney 293T cells, identifying 1435 
phospho-sites, 80% of which were novel. Moreover, they identified 60% more 
FPs with ETD compared to CID, mainly due to the 40% more fragment ions. It 
has to be remarked the little overlap between the two fragmentation techniques, 
that was exploited to develop an integrated approach. Since ETD works better 
with high charge peptides, Lys-C was thought to give better results than trypsin, 
cleaving the peptides only at C-terminal lysine. Surprisingly the results did not 
match expectations, probably due to the higher number of missed cleavages in 
the tryptic lysate (Molina H, 2007). Another way to generate highly charged 
peptides was attempted by Larsen et al, who added 0.1% m-nitrobenzyl alcohol 
(m-NBA) to the LC-MS solvent (Kjeldsen F, 2007). This approach increased the 
predominant charge from 2+ to 3+, improving the ETD results. The approach is 
currently being tested on more complex samples. Another fact to remark is the 
evolution of the software, born for the CID approach, in the direction of meeting 
the features of spectra generated by new enzymes and fragmentations (Kim S, 
2010), (http://www.matrixscience.com). 
 
Tab. 2-2. Comparison of fragmentation methods. All the methods show good 
results with a class of peptides, suggesting that an integrated approach CID/ECD 
or CID/ETD could be more effective (Molina H, 2007). 
 Fragmentation 
agent 
Generated 
ions 
Instruments Pros  Cons 
CID 
Inert gas  
(He, Ar) 
y, b ESI-MS 
Better fragmentation 
of low charge 
peptides (2+) 
Fragmentation 
mostly at the 
phosphogroup 
ECD Thermal electron z, c FT-ICR 
Fragmentation only 
along the peptide 
bond 
Need of 
expensive FT-ICR 
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ETD 
Low electron 
affinity anion 
(e.g.anthracene) 
z, c IT, Q-TOF 
Fragmentation only 
along the peptide 
bond 
Less sensitive 
than CID  
 
2.3.6 Quantitative approaches for phosphoproteome analysis 
In order to take a dynamic picture of the phosphorylation events in a particular 
pathway, it is desirable to monitor which sites are phosphorylated and to which 
extent following a stimulus. To achieve this goal some quantification methods 
are available and can be classified on the basis of the analysis step in which the 
quantitative information is generated: a differential isotopic label can be 
introduced in the cell culture, e.g. with labelled amino acids (SILAC), in the 
protein mixture (ICAT), in the enzymatic digestion (18O labelled water), or in the 
peptide mixture (iTRAQ), otherwise, in label-free experiments, the quantitative 
information is extracted at the MS level (Fig.7). A thorough review about 
quantitation strategies has been published by Bantscheff et al. (Bantscheff M, 
2007). 
 
 
Fig. 2-5. Strategies for quantitative analysis of protein phosphorylation. An 
isotopic label can be introduced in different moments of the analysis or not at all, 
in label-free experiments. 
2.3.6.1 Metabolic labelling 
Metabolic labelling was first described in 1999 (Oda Y, 1999). In 2002 Mann 
and co-workers introduced the term Stable Isotope Labelling by Amino acids in 
Cell culture (SILAC) and used it for quantitative analysis of protein 
LEVEL
CELL PROTEINS PEPTIDES MS
METHOD SILAC X
18O X
ICAT X X
iTRAQ X
LABEL-free X
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phosphorylation in 2003 (Ibarrola N, 2003). The typical experiment consists of 
growing a cell population in a medium containing an essential amino acid 
labelled with a stable isotope (15N or 13C), and growing in parallel another cell 
population in a medium on non-labelled amino acid. Usually labelled arginine 
and lysine are used, in order to ensure that every peptide from one culture 
contains a label after tryptic digestion. After several doublings, the cells are 
harvested from both cultures, and the protein extracts mixed together. After 
proteolysis, peptides can be analysed by MS and differences in the abundance 
of a peptide in the two cell extracts are shown through the different heights of 
two mass shifted peaks.  
Recently, with this method Olsen et al.(Olsen JV, 2006) reported the most 
comprehensive analysis of the effects of EGF stimulation on phosphoproteome 
dynamics in HeLa cells. This strategy has allowed the drawing of some detailed 
maps of time-resolved signalling pathways (Goss VL, 2006, Olsen JV, 2010). 
The major limitation of SILAC stays in the cost of labelled amino acids. 
 
2.3.6.2 Protein and peptide labelling 
Post-biosynthetic labelling of proteins and peptides is performed by chemical or 
enzymatic derivatisation in vitro.  
Enzymatic labelling exploits the incorporation of 18O atoms from isotopically-
enriched water during protein digestion. Trypsin and Glu-C introduce two heavy 
oxygen atoms, resulting in a 4 Da mass shift, generally sufficient for the 
differentiation of isotopomers. This method has been applied for quantitative 
proteomic purposes (Dengjel J, 2007), but complete labelling is difficult to 
obtain. 
Chemical modification can be carried out at the protein or peptide level by 
introducing a tag on a chemically reactive side chain of an amino acid (Ong et 
al., 2005), in practice only cysteine and lysine are used for this purpose. A 
group of labelling reagents targets the N-terminus and the ε-aminogroup in the 
lysine side chain. They mostly exploit N-hydroxysuccinimide (NHS) chemistry or 
other active esters and acid anhydrides, such as in the Isotope-Coded Protein 
Label (ICPL) (Schmidt A, 2005), isotope Tags for Relative and Absolute 
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Quantification (iTRAQ) (Ross PL, 2005), Tandem Mass Tags (TMT) (Thompson 
A, 2003) and acetic/succinic anhydride (Zhang X, 2002).  
iTRAQ is a commercially available reagent, allowing the evolution of biological 
systems to be followed over multiple time points. It was used, for example, to 
quantify 222 tyrosine phosphorylation sites across seven time points following 
EGF stimulation (Wolf-Yadlin A, 2007). 
Carboxylic groups of side chains of aspartic and glutamic acid as well as of the 
C-termini of peptidic chains can be isotopically labelled by esterification using 
deuterated alcohols, for example d0 and d3 methanolic HCl (Goodlett DR, 2001). 
This reaction is particularly interesting, since methylation is also a step used in 
the IMAC enrichment method to reduce non-specific binding of acidic peptides 
to the resin (Par. 2.3.4.2).  
General drawbacks of the chemical derivatisation methods are the production of 
undesired side products that negatively influence the quantification results and 
the cost of some of the reagents. 
2.3.6.3 Absolute quantification using internal standards 
The use of isotope-labelled internal standards in the field of proteomics is 
known with the name AQUA: Absolute QUAntification of proteins (Gerber SA, 
2003). 
The simplest protocol requires adding a known amount of a stable isotope-
labelled peptide to the protein digest and a comparison of its signal in the mass 
spectrum with respect the areas of other peaks (Pan S, 2005).  
There are some drawbacks with this approach. Firstly the high dynamic range 
of concentrations of peptides makes finding an appropriate concentration of 
standard for every analyte a difficult task; secondly, it is likely that a peptide 
isobaric with the standard will be found in the peptide mixture, therefore limiting 
its specificity. These problems, however, have been addressed with the 
approach called Multiple Reaction Monitoring (MRM) (Kirkpatrick DS, 2005), in 
which the triple quadrupole MS monitors the masses of both the peptide and its 
fragments during the experiment. The combination of retention time, peptide 
mass and fragment mass practically eliminates ambiguities, extending the 
dynamic range to 4-5 orders of magnitude (Bondarenko PV, 2002). The real 
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values determined by quantification through the AQUA approach are naturally 
biased by the manipulation of sample before adding the standard: the amount of 
protein determined may not therefore reflect its actual expression level in the 
cell. 
2.3.6.4 Label-free quantification 
There are two approaches for label-free quantification of proteins. The first one 
relies on the measurement of the area of an MS peak of a peptide related to a 
protein: the increase of this area means also an increased amount of the 
protein. This approach is called eXtracted Ion Chromatogram (XIC), because a 
single ion peak area is extracted from a plot of signal intensities against time in 
the chromatogram (Wang G, 2006). Signal intensities of the same peptide in 
different experiments is then compared to extract quantitative information, for 
example the stoichiometry of phosphorylation (Steen H, 2005). 
The other approach measures the amount of peptides generated from a protein: 
the greater the amount of protein the more are the tandem-MS generated 
peptides. Relative quantification is thus achieved by comparing the number of 
spectra generated from a protein in different experiments. It is necessary to 
perform a normalisation, for example depending on the protein mass, therefore 
creating Protein Abundance Indexes (PAIs) (Rappsilber J, 2002). The 
relationship between the number of peptides observed and the amount of 
protein has been found to be logarithmic in nature (emPAI) (Lu P, 2007). 
2.3.7 Non-MS approaches to elucidate cellular signalling networks 
2.3.7.1 Antibody-based approaches 
In order to monitor previously identified phosphorylation sites, arrays employing 
phosphospecific antibodies have been used to investigate dozens of 
phosphorylation sites simultaneously (Belluco C, 2005). The general hurdle to 
overcome with these techniques is the limited availability of dedicated 
antibodies, however further improvements could extend the use of microarray 
technology in phosphoprotein studies (Schmelzle K, 2006). 
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Methods were developed to monitor the phosphorylation status of tyrosine 
(Gembitsky DS, 2004) and the kinetics of phosphorylation (Khan IH, 2006) 
proteins in a multiplex format. 
In order to evaluate the phosphorylation dynamics on a cellular scale, flow 
cytometry approaches have also been devised to monitor up to 11 
phosphorylation events in parallel (Sachs K, 2005). Again, the main limitation of 
this approach is the availability of suitable fluorescently-labelled antibodies. 
2.3.7.2 Interaction of phosphoproteins and phosphorylated sites 
The phosphorylation-related events include also protein-protein interactions in 
the cell signalling network. To investigate these phenomena, Jones et al. (Jones 
RB, 2006) devised a protein array to study the binary interactions between 61 
fluorescent-labelled, tyrosine phosphorylated peptides from EGFR receptors 
with approximately 150 SH2 and PTB domains. By measuring the fluorescence 
at different titration points they determined the KD values for every peptide-
receptor couple.  
Another approach was followed by Yaoi et al. (Yaoi T, 2006), who immobilised 
SH2 domains on microspheres to extract interacting proteins and 
phosphoproteins from a complex mixture of different cell lines. 
Both approaches revealed new insights in the cellular signalling networks. 
2.3.7.3 Kinase screening in peptide and protein arrays 
Peptide microarrays consist of synthetic peptide sequences deposited onto 
glass slides or attached to a derivatised surface, usually in triplicate, with 
peptides having substitutions in the phosphorylation sites as controls. The in 
vitro phosphorylation reaction is performed in the presence of radiolabelled 
ATP, the array exposed to a film and the image captured. The method assumes 
that phosphorylation of peptides should be in most cases similar to that of the 
same sequence in the intact protein, due to the fact that many phosphorylation 
sites are in accessible and flexible regions of the protein structure (Nühse TS, 
2004). Collins et al. used this approach to investigate the phosphorylation of 
synaptic proteins, finding 28 unique phosphorylation sites (Collins MO, 2005).  
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Phosphorylation in vitro will naturally differ from that observed in vivo, but the 
screening can select and give priority to some phosphorylation sites for further 
investigation.   
The same approach can be used for immobilised proteins or protein domains. 
Ptacek et al. (Ptacek J, 2005) immobilised yeast proteins in high density arrays 
(4400 proteins in duplicate) on glass slides. They screened 87 kinases, finding 
that each kinase recognised up to 256 substrates, with an average of 47 
substrates per kinase. These data allowed the construction of a global kinase-
substrate interaction network. There is of course a concern about non-specific 
phosphorylation, but also the perspective of a high throughput analysis for 
mapping phosphorylation networks. 
2.3.8 Bioinformatics 
The knowledge discovery process in proteomics has been greatly boosted in 
recent years by the introduction of new bioinformatics tools.  
Widely used phosphoproteomics databases are, for example: PhosphoSite 
(Hornbeck PV, 2004) containing around 100,000 non-redundant 
phosphorylation sites (as well as other modifications, given that the cell 
signalling is not exclusively phosphocentric), and Phosida (Gnad F, 2007), 
containing temporal phosphorylation data from cell stimulation in time-course 
experiments.  
These databases not only permit mining of the data, but also the interpretation 
of data in the context of biological regulation, diseases, tissues, subcellular 
localisation, protein domains, sequences, motifs, etc. 
(http://www.phosphosite.org) 
2.3.9 Conclusion about phosphoproteomics 
Phosphoproteomics is a rapidly growing field, owing its evolution to the 
importance of protein phosphorylation in many biological processes and its 
alteration in many diseases.  
The analysis is usually performed with MS-based methods, supported by 
enrichment steps at the protein or peptide level. The improvements in MS have 
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been enormous, with increases in resolution, mass accuracy, greater dynamic 
range, sensitivity and speed, driving progress in this field. 
Of course the evolution of bioinformatics methods must also be mentioned, with 
the development of suitable software for literature mining, prediction algorithms, 
post-analysis annotation and so on. The aim of phosphoproteomics is not only 
to find phosphorylation sites, but also to monitor the dynamics of 
phosphorylation following stimuli to characterise completely signalling networks. 
Nowadays the phosphoproteome of highly complex samples has been tackled 
(Trinidad JC, 2006, Villen J, 2007), but further development of the methods, 
including bioinformatics tools capable of integrating complex databases, is 
needed for a more thorough knowledge of the mechanisms of phosphorylation 
networks.  
2.4 Molecularly Imprinted Polymers 
A relatively recent technique to develop affinity receptors that could find 
interesting applications in pre-fractionation is the molecular imprinting of 
polymers (MIPs). MIP permits the synthesis of materials with designed 
recognition properties, by exploiting a “template” mediated synthesis, where the 
“template” is a molecule of interest. During the polymerisation, functional 
monomers assemble around the template either via reversible covalent bonds 
(Wulff G, 1991). or via non-covalent interactions such as hydrogen bonds, ionic 
bonds, hydrophobic interactions, van der Waals forces, etc. (Sellergren B, 1989, 
Mosbach K, 1994). 
The pre-assembly is locked-in by crosslinking, forming a polymer with 
embedded molecular depressions, or clefts, complementary to the template in 
size, shape and functionality. 
Molecular imprinting of small molecules such as herbicides, metal ions or amino 
acids has been successfully accomplished and numerous papers express the 
potential of such materials as sensors (Mosbach M, 2001, Piletsky SA, 2001), 
chromatography beds (Cormack PAG, 2007, Kempe M, 1994), synthetic 
antibodies (Ye L, 2001, Vlatakis G, 1993), synthetic enzymes (Leonhardt A, 
1987, Wulff G, 2002) or systems for controlled drug release (Sellergren B, 2005, 
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Cunliffe D, 2005). These studies demonstrate that imprinted materials might 
exhibit very high selectivity and even enantioselectivity (Leonhardt A, 1987). 
2.4.1 MIPs for proteins and peptides 
A particular challenge concerns the development of MIPs to recognise large 
target molecules such as peptides and proteins. The complexity of such a 
process has been attributed to several reasons (Bossi A, 2007). Firstly, large 
molecules are not able to diffuse through the polymeric network, limiting the use 
of crosslinking that proved to be successful in preserving the imprints. 
Secondly, the relative non-rigidity of proteins and the ease of unfolding may 
lead to the formation of poorly-defined recognition sites. Thirdly, the poor 
solubility of most proteins in most organic solvents limits the synthesis 
conditions.  
In addition, large molecules possess a number of potential binding groups and 
the choice of the functional monomers plays a crucial role in determining the 
quality of the imprints. In the case of large biomolecules, it was suggested to 
exploit the biochemical information on the natural receptors of the target 
proteins, as a starting point in the decision process towards the definition of the 
monomer composition (Cecìlia A, 2005).  
To overcome the limitations posed by the complexity of protein structure, it has 
been proposed to imprint only part of the protein. The short peptide sequences 
selected are called epitopes (Rachkov A, 2001). 
Regarding peptides imprinting, Kempe and Mosbach (Kempe M, 1995) 
demonstrated chiral separation of small peptide sequences with highly cross-
linked MIPs. In another study, Kempe (Kempe M, 2000) developed a MIP able 
to recognise Z-oxytocin peptide, despite the selectivity of rebinding not being 
remarkable. In a more systematic study, carried out by Klein et al. (Klein JU, 
1999), imprinting of tripeptide sequences was assayed, with specific binding of 
approximately 30% for the print sequence and much lower binding of other 
similar sequences. Finally, Hart and Shea (Hart BR, 2001) proposed metal 
affinity (Ni2+) to histidine terminal groups and obtained a quite successful 
peptide imprinting.  
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A different strategy to address the issue of protein imprinting consists of surface 
aided imprinting, which attempts to produce successful imprints by depositing 
the proteins onto a support, thus taking advantage; 1) of the orientation of the 
template, and 2) of the problems linked to template entrapment. Proteins have 
been at first deposited on/immobilised to a solid surface and subsequently the 
polymer has been grown (Shi HQ, 1999, Bossi A, 2001, Shiomi T, 2005).  
A wide choice of supports and materials have been used: polysiloxanes in the 
very early study of Glad et al. (Glad M, 1985) who demonstrated the  successful 
imprinting of the glycoprotein transferrin and later Lulka et al. (Lulka MF, 2000) 
created a MIP for ricin over silica particles. Fluoro-polymer films were prepared 
by Ratner and co-workers (Valdes TI, 2008) by radio frequency glow discharge 
plasma deposition to form films around proteins deposited on a mica surface 
previously coated with disaccharide molecules. Bossi et al. (Bossi A, 2000) 
coated polystyrene microtiter plates with a thin layer of a stable conjugated 
polymer (aminophenyl boronic acid) polymerised in the presence of various 
protein templates. Rick and Chou (Rick J, 2006) imprinted proteins in thin layers 
of aminophenylboronic acid and used micro-calorimetry measurements to 
assess the enthalpy changes associated with the rebinding and the imprinting 
efficiency.  
To address the issue of the non-compatibility of proteins with organic solvents, 
some research groups have been working with imprinting in aqueous 
conditions, thus with water compatible polymers, which ensures solubility and 
conformational stability of the proteins. Despite these advantages, the results 
are still limited. Hjerten and co-workers (Hjertén S, 1989) pioneered the use of 
lightly crosslinked polyacrylamide hydrogels as the polymeric matrix. Hirayama 
et al. (Chao GT, 2008) incorporated charged functional groups (either positive 
or negative) in polyacrylamide gels in an attempt to achieve a better recognition. 
Ou et al. (Ou SH, 2004) combined polyacrylamide simultaneously with two 
functional monomers, methacrylic acid and 2-(dimethylamino)ethyl 
methacrylate.  
A drawback of hydrogel protein imprinting is the amount of protein template that 
remains entrapped in the MIP is generally high, due to diffusional limitations and 
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the collapse of local polymeric environments. In an attempt to ameliorate the 
rigidity of the hydrogel architecture, Gou et al. (Zhu WP, 2008) developed a 
composite material, by insertion of imprinted polyacrylamide gel into the pores 
of chitosan or modified chitosan beads. The results achieved with protein and 
peptide imprinting still needs to be improved, if the final goal of these materials 
is to compete with natural receptor systems. MIP methods for the selective 
recognition of specific peptide sequences and/or proteins remain a significant 
challenge.  
2.4.2 MIPs for proteome with particular attention to 
phosphopeptides 
Of particular interest in the proteome era is the use of MIPs for phosphopeptide 
(FP) enrichment prior to proteomic MS analysis.  
The works published deal quite exclusively with the preparation of MIPs for 
inorganic phosphates, and are mostly targeted to agricultural/waste water 
subjects (Kugimiya A, 2008, Yamazaki T, 2001). Sellergren’s group tried to 
develop MIP-based method for FP enrichment, achieving a positive indication of 
its feasibility, but still showing limited success (Emgenbroich M, 2008). Most of 
the papers dealing with phospho-groups converge in assessing the 
effectiveness of urea and thiourea monomers for the capture (Helling H, 2011). 
2.5 Synthesis and characterisation of MIP nanoparticles 
selective for peptides containing phosphotyrosine 
The purpose of this research line is to develop a selective material for pTyr-
containing peptides. The application of such material will be primarily as an 
alternative to antibodies, largely employed in phosphoproteome analysis to 
selectively enrich phosphoproteins and/or phosphopeptides present in a protein 
or peptide mixture. The advantage of MIPs “plastic antibodies” with respect to 
their natural counterparts is the potentially much lower cost of their production 
plus resistance to harsh conditions (pressure, temperature, basic or acidic pH) 
and in general a higher stability: they can also be used in both aqueous and 
organic solvents (Ye L, 2008). In perspective, the nano size of MIPs (nanoMIPs) 
further points out their use in vivo to selectively target a phosphorylated epitope, 
for which a suitable plastic antibody has been devised. This opens the exciting 
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scenario of diagnostic and therapeutic molecules specifically tailored to the 
target by using itself as a model template. What stands as a remarkable 
example of biomimicry is the recent report of Kenneth Shea and colleagues, 
who devised a plastic antibody specifically directed against the peptide mellitin, 
a component of bee venom. These MIP nanoparticles worked in vivo, by 
removing a lethal amount of toxin from the circulation of mice and significantly 
reduced their mortality (Hoshino Y, 2010).  
The first step of the nanoMIP synthesis process consists of optimisation of the 
production method for nanoparticles, which should be of suitable size and 
polydispersity. Their use in vivo requires for example a size ideally less than 
100nm (similar in size to viruses) to penetrate living cells and translocate within 
the body (Perrault SD, 2009) moreover a Polydispersity Index, associated with 
a homogeneous population (see next paragraph), should be ideally less than 
0.2 (Müller RH, 1993), (www.malvern.com). It should be noted that the 
definitions of Polydispersity Index (PdI) used in Dynamic Light Scattering theory 
(see next paragraph) and in polymer science are different, moreover in the latter 
the values of PdI are equal to or greater than 1. A particle size similar to the 
size of proteins greatly facilitates the diffusion of the protein itself through the 
matrix, reducing the time of analysis (Wulff G, 2012, Ye L, 2001). The same 
method of synthesis is subsequently used in the presence of the template 
molecule to create its print in the nanoparticle. The molecule is then removed 
and the remaining cavities maintain the ability to rebind the same molecule due 
to their size and chemistry (functional groups of monomers oriented to 
compatible groups of the template during the polymer synthesis). The imprinted 
and non-imprinted nanoparticles are then tested for specificity, selectivity and 
capacity (see Par. 2.5.4). 
Between the different ways of nanoparticles synthesis, photopolymerisation 
seemed to be a valuable choice. This method employs a starter triad composed 
of a coloured antenna, a reducer and an oxidiser, that in this case were 
methylene blue (MB), toluenesulphinic acid (TSIA) and diphenyliodonium 
chloride (DPIC), as suggested by Righetti et al. (Lyubimova T, 1993) (Fig. 2-6). 
The described mechanism employs MB, activated by light, to form an excimer 
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with TSIA, by which it is reduced. TSIA radical is an active one, while MB 
radical is passive, thus terminates the polymerisation chain reaction. The 
purpose of DPI is to boost the reaction through MB˙ oxidation to form an active 
radical Ph  while regenerating MB* (Fig. 2-6) (Kim D, 2004 ). This method 
permits control to be exerted over the polymer growth through a light-switch-like 
mechanism. 
 
 
 
Fig. 2-6. Chemical structures of the three compounds employed as starter triad 
for the photopolymerisation process: A) Methylene blue (MB), B) 
Diphenyliodonium chloride (DPI), C) Toluenesulphinic acid (TSIA), plus the 
mechanism of activation: a visible-light-induced electron transfer initiation 
process (Kim D, 2004 ). 
2.5.1 Techniques for nanoparticles physical characterisation 
The physical characterisation of the nanoparticles can be made with a variety of 
different techniques, addressed to understand and control their synthesis and 
applications. Some widely used techniques are Transmission Electron 
Microscopy (TEM), Scanning Electron Microscopy (SEM) and Atomic Force 
Microscopy (AFM), mainly devoted to visualise the particles and thus explore 
their morphology plus other characteristics such as aggregation. Other 
techniques such as X-ray Photoelectron Spectroscopy (XPS) evaluate instead 
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surface characteristics such as chemical composition or electronic state 
(Rudenberg HG, 2010). Dynamic Light Scattering (DLS) is another widely used 
technique that allows an assessment of particle size, particle number and 
tendency to aggregation to be made (Berne BJ, 2000). In this project AFM and 
DLS were used. 
2.5.1.1 Dynamic Light Scattering  
Dynamic Light Scattering (DLS) is a physical technique employed to determine 
size distribution of particles in solution. The physical phenomenon at its basis is 
Rayleigh scattering, i.e. the diffusion of light in all the directions from particles 
smaller than the wavelength of light used (Chu B, 1992). When the light is 
coherent and monochromatic, such as that from a laser, constructive and 
destructive interference occurs between the light emitted by the scatterers. This 
interference changes continuously with time due to Brownian motion of the 
particles. By detecting the light intensity at a certain angle (usually 173° respect 
to the light source) an intensity fluctuation can thus be observed. This 
fluctuation is faster for fast-moving particles, thus depends on the size of the 
particles, on their shape and on the temperature and viscosity of the medium. 
The fluctuation is mathematically expressed by the autocorrelation function (Eq. 
2-1): 
 
Eq. 2-1. 
where g2(q;τ) is the autocorrelation function at a particular wave vector q, and 
delay time τ, and I is the intensity. At short time delays τ the correlation is high, 
meaning that intensity changed very little due to the little motion of the particles. 
At longer time delays the correlation between intensities instead decreases 
exponentially and depends essentially on the diffusion coefficient of the 
particles (Fig. 2-7).  
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Fig. 2-7. Representation of the principle of Dynamic Light Scattering. Smaller 
particles give quicker fluctuations of a scattered laser light, as evidenced by the 
correlation function (picture taken from: Wikipedia). 
 
Information about the particles can be extracted by fitting the decay of the 
autocorrelation function. Numerical methods are employed for the purpose and 
they are essentially based on an assumed size distribution. For example, if the 
sample is monodisperse the decay is fitted well by a simple exponential (Eq. 
2-2): 
 
Eq. 2-2. 
where Г is the decay rate. The translational diffusion coefficient can be derived 
from the wave vector q and Г according to Eq. 2-3: 
 
Eq. 2-3. 
where q is (Eq. 2-4): 
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Eq. 2-4. 
where λ is the incident laser wavelength, n0 is the refractive index of the sample 
and θ is the angle at which the detector is positioned respect to the light source. 
Through the Stokes-Einstein equation (Eq. 2-5) is therefore possible to derive 
the hydrodynamic radius of the particles: 
 
Eq. 2-5. 
In this equation D is the diffusion coefficient, kB the Boltzmann’s constant, T the 
temperature, η the viscosity of the medium and r the radius of the spherical 
particle. 
In most cases, however, the sample is polydisperse and the autocorrelation 
function is the sum of exponential decays of all the species in solution (Eq. 2-6):  
 
Eq. 2-6. 
In this case a commonly used mathematical model to describe the system is the 
cumulant method. This model introduces the variance of the system as 
Polydispersity Index (Eq. 2-7): 
 
Eq. 2-7. 
where  is the average decay rate and  is the second order Polydispersity 
Index. 
It should be noted that DLS gives information on the hydrodynamic diameter of 
spherical particles, meaning that it models the behaviour of irregularly shaped 
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objects as if they were spheres. Moreover the measured size considers also the 
layer of solvent or ions around the particles. This information is therefore 
generally different from what can be measured for example with electronic 
microscopy such as TEM, that “sees” the naked particles (Egerton R, 2005). 
2.5.1.2 Atomic Force Microscopy 
The Atomic Force Microscope (AFM) is an instrument belonging to the class of 
the Scanning Probe Microscopes (SPM). Its spatial resolution is of the order of 
nanometres making it particularly useful in the study of nanoparticles, including 
both their morphology and their interactions with partners. 
The AFM consists of a silicon or silicon nitride cantilever, with a tip of the radius 
of curvature of the order of nanometres (Fig. 2-8). The tip moves along the 
surface to sample all the relief and depressions. Interactions of the probe with 
the surface are: mechanical contact force, van der Waals forces, capillary 
forces, chemical bonding, electrostatic forces, magnetic forces, Casimir forces, 
solvation forces, etc (Giessibl FJ, 2003). 
The area scanned is typically of the order of microns in the x and y-dimensions. 
A laser beam impinges on the upper surface of the cantilever, the light being 
reflected and detected by a diode microarray. The detected ray of light gives 
rise to an electric signal which is digitised, elaborated and transformed in a 
reconstructed image of the surface (topography) by dedicated software. 
There are basically three ways of profiling a surface: contact mode, non-contact 
mode and tapping mode. 
In contact mode the tip passes close to the surface keeping the interaction 
between them constant. The force must be repulsive in this case, in order to 
avoid snapping of the tip. 
In non-contact mode there is no contact between the surface and the tip: the 
cantilever oscillates at a frequency slightly higher than its resonance frequency 
with an amplitude of few nanometres (< 10 nm). The interaction with the surface 
tends to decrease the frequency of oscillation, but a feedback loop system 
keeps it constant by modifying the average distance between tip and surface.  
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In intermittent contact, or tapping mode, the oscillation has a greater amplitude 
(100-200nm) and the tip intermittently touches the surface. This technique is 
well suited for soft matter, such as lipid bilayers. 
With AFM it is also possible to evaluate interaction forces by binding a ligand to 
the tip and scanning its interaction with a receptor immobilised to the surface 
(Butt H, 2005). 
AFM measurements in liquid samples are also possible, thus preserving the 
nature of labile molecules such as proteins (Hinterdorfer P, 2006). 
 
Fig. 2-8. Representation of how Atomic Force Microscopy works. A nanometric 
size tip moves along a surface surveying relieves and depressions. A laser beam 
is reflected by the upper part of a cantilever that bears the tip and impinges to a 
detector. This information is interpreted by a software that reconstructs the 
surface topology (picture taken from: http://www.nanoatlas.ifs.hr). 
2.5.2 Nanoparticle synthesis  
Different recipes were followed to find the best approach to produce 
nanoparticles of suitable size (diameter ideally less than 100nm) with low PDI 
and high yield in their production.  
A Fmoc-protected phosphotyrosine (Fmoc-pTyr) was used as template, as 
suggested by Sellergren et al. (Emgenbroich M, 2008).  
Regarding the choice of functional monomers, positively charged monomers 
could be thought of as effective for the phosphate group. Their choice is 
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however not advisable because of the bias introduced in imprinting: charged 
monomers are attracted by the charges independently of the molecule 
structure, i.e. the sequence of amino acids in the case of peptides and/or 
proteins (Emgenbroich M, 2008). 
Instead, the functional monomers chosen were 2-hydroxyethyl methacrylate 
(HEMA) and 1,3-diallylurea (DAU), while cross-linkers were N,N’-methylene-bis-
acrylamide (BIS) and 1,4-bis(acryloyl)piperazine (BAP).  
HEMA showed good properties in producing hydrogels, and is extensively used 
in commercial products, such as contact lenses, for its swelling properties 
(Karlgard CCS, 2003). The production of a soft polymer such as a hydrogel is 
necessary when working with proteins, to permit their internalisation in the 
polymer matrix (Brahima S, 2002). Diallylurea has similar properties to the 
suggested monomers for phosphotyrosine imprinting, as recently reported by 
Sellergren et al. (Emgenbroich M, 2008). BIS is a commonly used cross-linker 
for protein/peptide imprinting and for gel electrophoresis matrixes (Kryscio DR, 
2012, Righetti PG, 2005). BAP shows instead better mechanical characteristics 
(keeping the shape) respect to BIS, and this is the reason for its choice in 
protein imprinting (Kirat KE, 2009). The synthesis was carried out in two 
solvents. The aqueous solvent was 100mM, pH 8.20 Tris buffer, that does not 
show interference with the binding with pTyr (like a more “physiological” PBS) 
but at the same time is largely employed in proteomics (Rabilloud T, 2010). 
2.5.3 Bulk synthesis 
Finally, the bulk synthesis (Tamayo FG, 2007) out of two recipes, chosen 
according to AFM and DLS results, was carried out. Rebinding experiments 
were performed on this material in order to collect preliminary information in 
standardised conditions before using nanoparticles. The method consists of the 
preparation of a solid polymer subsequently crushed and sieved to give micron-
sized particles. 
2.5.4 Functional characterisation of MIPs 
Functional characterisation of MIPs consists of an assessment of the following 
characteristics:  
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capacity: amount of template that can be bound by 1 mg of polymer;  
specificity: affinity of the template for MIP, expressed by the equilibrium 
dissociation constant KD; 
selectivity: ability of MIP to discriminate between the template and other 
substrates; 
imprinting factor: ratio between the amount of substrate bound from MIP and 
from its non-imprinted counterpart (Non-Imprinted Polymer, NIP). 
MIPs ability to rebind the template from its solutions can be evaluated as 
follows. A fixed amount of MIP and of NIP is put in contact with increasing 
concentrations of template molecule. After incubation the amount of free 
substrate [A] is evaluated in solution, therefore assessing its amount bound to 
the resin [AB] by subtracting it from the initial amount of substrate [A]i (Eq. 
2-11). A graph of substrate bound [AB] respect to the ratio [AB]/[A] (Scatchard 
plot, Fig. 2-9) permits an evaluation of the affinity constant (KD) of the substrate 
for the polymer (Eq. 2-9) and the maximum amount of guest bound (the 
capacity, or the apparent maximum number of binding sites [B]max) given 
respectively by the slope and the intercept of the Scatchard equation (Eq. 2-10). 
In an ideal 1:1 interaction between substrate and homogeneous binding sites of 
the polymer (Eq. 2-8), KD is defined as follows: 
 
Eq. 2-8. 
 
Eq. 2-9. 
 
Eq. 2-10. 
[AB] 
[A] 
____ 
= 
[B]max – [AB] ___________ 
K
D
 
K
D 
 =  
[A] [B] 
[AB] 
_____ 
A  +  B AB 
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Eq. 2-11. 
 
The nature of the binding sites is never uniform and more kinds of guest-binding 
sites exist (Matsui J, 1995). This characteristic is evidenced by a non-linear 
graph such as Fig. 2-9, whose slopes give the value of two KDs. 
 
Fig. 2-9. Scatchard plot to estimate the binding nature of the polymer. Two kinds 
of binding sites are evidenced by two different slopes in the graph. 
2.5.5 Materials and methods 
2.5.5.1 Materials 
Reagents 2-hydroxyethyl methacrylate (HEMA), 1,4-bis(acryloyl)piperazine 
(BAP), toluensulphinic acid (TSIA), diphenyliodonium chloride (DPI) and 
methylene blue (MB) were purchased by Fluka (Steinheim, DE); 1,3 diallylurea 
(DAU) was an Aldrich product obtained from Sigma-Aldrich (St.Louis, MO, 
[AB] 
[AB] 
____ 
[A] 
[A] = [A]
i
 – [AB] 
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USA); N,N’-methylene-bis-acrylamide (BIS) was a BioRad product (Hercules, 
CA, USA).  
2.5.5.2 Small-scale synthesis of the nanoparticles 
The list of recipes related to the synthesised polymers is reported in Tab. 2-5 
(Par. 2.5.6.1). Fmoc-protected phosphotyrosine was added in some samples at 
the ratio 1:2 with respect to the functional monomer, as suggested by Sellergren 
et al. (Emgenbroich M, 2008). 
Synthesis was carried out either in 100mM Tris buffer pH 8.20 or in 
acetonitrile/water 9:1 v/v. All syntheses were made in a final volume of 3 mL 
and in 6 mL HPLC vials with silicon reversible cap. Samples were treated with 
an argon flow for 10 min prior to illumination. Irradiation was performed with a 
VIS transilluminator lamp (40W).  
2.5.5.3 Dialysis of the nanoparticles 
After the synthesis samples were dialysed straightaway by using a dialysis 
tubing cellulose membrane (Sigma) with cut-off 12000 Da. MilliQ water was 
used as receptor medium. Dialysis took place for 48h with 3 changes of solvent. 
The sample volume/receptor medium ratio was 1:400. 
2.5.5.4 Size analysis of the nanoparticles 
The size of the synthesised nanoparticles was determined by the Dynamic Light 
Scattering (DLS) technique on a Zetasizer Nano ZS instrument equipped with 
633nm laser and DTS Ver. 4.10 software package (Malvern Instruments Ltd., 
Worcestershire, UK). All samples were sonicated for 20 min prior to analysis 
and filtered on a 0.45 µm filter to eliminate large sedimenting particles. A 180 
sec equilibration time was needed for the sample to reach ambient temperature 
(25 °C) after sonication. The mean value of the particle size was calculated from 
the results of three measurements on each sample. The light was collected at 
an angle of 173° with respect to the incident laser light. Size measurement 
results are reported in Tab. 2-6.  
2.5.5.5 Yield of the nanoparticles 
The yields of the syntheses were calculated for the samples, as reported in 
Tab.2.3. Ten ml of solution containing nanoparticles were dialysed and freeze 
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dried in pre-weighed Falcon polypropylene tubes. Yields were calculated with 
respect to the initial amount of monomers. 
2.5.5.6 Atomic force microscopy of the nanoparticles 
AFM measurements were made on four samples produced with four different 
recipes, chosen according to DLS measurements. The best for size and PdI 
recipes were chosen, considering however to not exclude monomers, cross-
linkers or solvents that could furnish interesting morphological or aggregation 
characteristics. The instrument was an NT-MDT Solver P47H-PRO AFM. Mica 
dishes (Ted Pella) were freshly peeled with sticky tape before sample 
deposition. Samples (not dialysed) were sonicated for 5 min, diluted 1:1 (v:v) 
with ethanol and 50 µl of the mixture was deposited on mica dishes. After 5 min 
the dishes were washed by dipping into 0.20 μm filtered MilliQ water and dried 
for 20 sec with an air flow. Images were collected at room temperature (20 °C) 
in semi-contact mode using NT-MDT NSG11 silicon cantilevers with Au 
backside coating, with a minimal applied force at a scan frequency of 0.5-2 Hz 
with 512 pixel resolution.  
2.5.5.7 Large-scale synthesis of the nanoparticles 
Eight recipes were produced on a larger scale. The recipes were chosen 
according to DLS measurements as explained in Par. 2.5.5.6. Moreover a 
choice of a variety of monomers, cross-linkers and solvents could offer 
interesting characteristics of rebinding. The recipes chosen are listed in Tab. 2-
3. The reactions were carried out in borosilicate glass bottles in a final volume 
of 100 mL after argon bubbling for 10 min. Irradiation was performed with a VIS 
transilluminator lamp (40W) under gentle stirring (250rpm).  
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Tab. 2-3. Samples produced on large scale (W=Tris 100mM, pH8.2; 
A/W=ACN/Water 9:1 v/v). 
Recipe Monomers % T 
% 
Cm 
Time 
polym.  
mmol (mg) 
Cross 
linker 
mmol (mg) 
monomer 
mmol  
(mg)  
Fmoc-
pTyr 
solvent 
F HEMA/BIS 1 80 5' 
6.30  
(974) 
1.58  
(206) 
 W 
F+pTyr HEMA/BIS 1 80 5' 
6.30  
(974) 
1.58 
(206) 
0.79 
(382) 
W 
H1 HEMA/BAP 1 67 5' 
4.55 
(884) 
2.27 
(148) 
 W 
H1+pTyr HEMA/BAP 1 67 5' 
4.55 
(884) 
2.27 
(148) 
1.13 
(532) 
W 
L3 HEMA/BIS 0.2 80 18h 
1.26 
(195) 
0.32 
(41) 
 A/W 
L3+pTyr HEMA/BIS 0.2 80 18h 
1.26 
(195) 
0.32 
(41) 
0.16 
(77) 
A/W 
M3 DAU/BIS 0.2 80 18h 
1.26 
(195) 
0.32 
(45) 
 A/W 
M3+pTyr DAU/BIS 0.2 80 18h 
1.26 
(195) 
0.32 
(45) 
0.16 
(77) 
A/W 
 
2.5.5.8 Dialysis of the nanoparticles 
After synthesis the samples were dialysed straightaway by using a dialysis 
tubing cellulose membrane (Sigma) with cut-off 12000 Da. MilliQ water was 
used as dialysate. Dialysis took place for 96 hours with 12 changes of solvent. 
The sample volume/dialysate ratio was 1:50. 
2.5.5.9 Electrodialysis of the nanoparticles 
Dialysed nanoparticles were electrodialysed for 4h with a set current of 500 V, 
5.0 mA, 1 W. Samples were put in a 3500 KDa cut-off SpectraPor membrane 
with addition of 10mM histidine (Sigma). Anodic buffer was 1 L of a 10 mM 
histidine solution. After electrodialysis samples were dialysed again for 4 h 
against 1 L of MilliQ water with the same membrane. 
2.5.5.10 Concentration of the nanoparticles 
Electrodialysed samples were concentrated with Centriprep YM30 centrifugal 
filter devices (30 kDa cut-off, Millipore). The applied centrifugal force was 1500 
x g for 15 min, according to manufacturers’ instructions. An initial volume of 100 
mL was reduced to 10 mL. 
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2.5.5.11 Yield evaluation of the nanoparticles 
One mL of every concentrated solution, corresponding to 10 mL of initial 
nanoparticles solution, was put in previously weighed 6 mL HPLC vials to 
quantify the presence of particles. Samples were freeze-dried for 24h and the 
weight measured with a Ohaus Explorer balance. 
2.5.5.12 Standard bulk synthesis 
Two recipes were chosen to produce bulk polymers and perform rebinding 
experiments. This operation was made to gain an idea of the binding properties 
of the material under standardised conditions. 
Solvents: acetonitrile, methanol and hydrochloric acid, used to clean the 
synthesised polymers from Fmoc-pTyr, unreacted species and pTyr after 
rebinding, were purchased from Carlo Erba (Milano, Italy). 
A 500 mg of HEMA/BIS 80%C and DAU/BIS 80%C were dissolved in 8 mL Tris 
buffer 20 mM, pH 8.20 (final total monomers content 6%T) and divided in two 
6mL HPLC vials to prepare the non-imprinted polymers (NIPs, controls).  
In a second aliquot Fmoc-pTyr was added with a molar ratio 1:2 with respect to 
the functional monomer to prepare the molecularly imprinted polymers (MIPs, 
see Tab. 2-4). Methylene blue, diphenyliodonium chloride and toluenesulphinic 
acid were subsequently added to all the aliquots to achieve a final concentration 
of 100µM, 50µM and 1 mM respectively before being treated with an argon flow 
for 5 min prior to illumination. Irradiation was performed with a VIS 
transilluminator lamp (40W). Aluminium foil was used to wrap the reaction 
environment and thus illuminate the reactor from every direction. The 
illumination duration was 4h for HEMA/BIS and 16h for DAU/BIS. The recipes 
were as follows: 
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Tab. 2-4. Recipes of the synthesised bulk polymers. 
Recipe 
Monomer 
(mg / µmol) 
Cross-linker 
(mg / µmol) 
Fmoc-pTyr  
(mg / µmol) 
HEMA/BIS (NIP) 87 / 668 413 / 2679  
HEMA/BIS + Fmoc-pTyr (MIP) 87 / 668 413 / 2679 161 / 334 
DAU/BIS (NIP) 93 / 663 407 /2641  
DAU/BIS + Fmoc-pTyr (MIP) 93 / 663 407 / 2641 160 / 331 
 
2.5.5.13 Polymer cleaning and drying 
After the synthesis the polymer samples were cleaned through a series of 
washing steps to remove the unreacted monomers, initiators and Fmoc-pTyr. 
The solvent used were in order: acetonitrile/water 1:1 v/v, acetonitrile, 
methanol/HCl 0.1M 1:1 v/v.  
The synthesised HEMA/BIS NIP and MIP were put in 50 mL Falcon tubes and a 
volume of solvent 4 times the amount of polymer was added, mixed on an 
orbital rotor and centrifuged at 3000 x g for 20 mins, at 25°C. The synthesised 
DAU/BIS NIP and MIP, after the solvent addition, were divided into aliquots in 2 
mL Eppendorf tubes, mixed on the orbital rotor for and centrifuged at 10000 x g 
for 20 minutes, at 25°C. This different treatment was needed because DAU/BIS 
MIP would not sediment at low speed. The supernatants were then drained, 
analysed with UV-VIS spectrometry and replaced with fresh solvent. The graphs 
of the cleaning steps are reported in Fig. 2-43 and Fig. 2-44. Absorbance was 
measured with an Unicam UV2 UV-VIS spectrometer, at wavelength λ = 214 
nm in quartz cuvettes, to evaluate the presence of double bonds (unreacted 
monomers).  
After cleaning, samples were spread on cellulose paper and left at ambient 
temperature (25 °C) for 72 h until dryness. The weights of the dry polymers are 
reported in Tab. 2-10. Yields were calculated respect to the initial amount of 
monomers. 
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2.5.5.14 pTyr calibration curve 
In order to evaluate the presence of pTyr in rebinding experiments two 
calibration curves were made. Firstly pTyr (Sigma) was dissolved in PBS buffer 
+ 0.02% Tween-20 at increasing concentrations. The first curve was produced 
with an Unicam UV2 UV-VIS spectrometer, at wavelength λ = 272 nm in quartz 
cuvettes. The second one was obtained with a Jasco FP8200 
spectrofluorimeter, in quartz cuvettes, at λexc = 265 nm and λem = 297 nm. All the 
measurements were made in triplicate.  
2.5.5.15 Rebinding experiments 
After extensive cleaning the polymers were subjected to rebinding experiments 
to evaluate capacity (μg substrate bound by 1mg of polymer) and affinity (KD). 
Due to the limited amount of DAU/BIS polymer, only HEMA/BIS polymer was 
subjected to these measurements. 
Ten mg aliquots of HEMA/BIS NIP and MIP were put in contact with 2 ml of 
increasing concentrations of pTyr and gently shaken on an orbital rotor for 4 
hours. Then the solutions were centrifuged at 10000 x g for 20 min at 25°C. The 
supernatant was drained and filtered through a 0.22 m cellulose membrane to 
eliminate material in suspension. The pTyr concentration was evaluated on the 
initial solutions and on the drained solutions with a Jasco FP8200 
spectrofluorimeter, in quartz cuvettes, at λexc = 272 nm and λem = 297 nm. 
Absorbance data from the initial solutions were used to produce a calibration 
curve, from which concentrations could be calculated. The difference between 
the concentration of the initial solutions and of the same solutions left in contact 
with the polymer gives the amount of pTyr bound to the polymer. Then the pTyr 
bound per mg of polymer was calculated and the maximum capacity estimated. 
2.5.5.16 Cleaning after rebinding 
Polymers subjected to rebinding experiments were cleaned through a series of 
passages in Methanol/HCl 0.1M 1:1 solution in ratio 20:1 with respect to the 
polymer amount. The presence of pTyr was evaluated through absorbance 
measurements at wavelength 272 nm.  
Cleaning passages were repeated until an absorbance < 0.01 was detectable 
(Tab 2-11, Fig. 2-47). 
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2.5.6 Results and discussion 
2.5.6.1 Recipes 
Nanoparticles were synthesised modifying the following parameters: type of 
monomers and cross-linkers, polymerisation time, initiators amount, stirring, 
molar cross-linker percentage (%Cm), presence of template.  
The samples were synthesised in triplets. Thirty-five different conditions were 
explored, and they are listed in Tab. 2-5.  
Tab. 2-5. List of polymerisation nanoparticles recipes. W= TRIS buffer 
100mM, pH8.2; A/W=Acetonitrile/Water 9:1 v/v. 
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A1 HEMA/BIS 1 46 100 1 50 5' y W   
A2 HEMA/BIS 1 46 100 1 50 10' y W   
A3 HEMA/BIS 1 46 100 1 50 30' y W   
A4 HEMA/BIS 1 46 100 1 50 60' y W   
C HEMA/BIS 1 46 10 1 50 10' y W   
D HEMA/BIS 1 46 10 0.1 5 10' y W   
B1 HEMA/BIS 1 46 100 1 50 5' n W   
B2 HEMA/BIS 1 46 100 1 50 10' n W   
G HEMA/BAP 1 40 100 1 50 5' y W   
E1 HEMA/BIS 1 72 100 1 50 5' y W   
E2 HEMA/BIS 1 72 100 1 50 10' y W   
H1 HEMA/BAP 1 67 100 1 50 5' y W   
H2 HEMA/BAP 1 67 100 1 50 10' y W   
F HEMA/BIS 1 80 100 1 50 5' y W   
P HEMA/BIS 1 80 100 1 50 5' y W y 
L1 HEMA/BIS 0.2 80 100 1 50 10' y A/W   
L2 HEMA/BIS 0.2 80 100 1 50 60' y A/W   
L3 HEMA/BIS 0.2 80 100 1 50 18h y A/W   
M1 DAU/BIS 0.2 80 100 1 50 10' y A/W   
M2 DAU/BIS 0.2 80 100 1 50 60' y A/W   
M3 DAU/BIS 0.2 80 100 1 50 18h y A/W   
I1 HEMA/BIS 0.2 80 100 1 50 5' y W   
 
          continue... 
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...continue 
I2 HEMA/BIS 0.2 80 100 1 50 60' y W   
J DAU/BIS 0.2 80 100 1 50 5' y W   
S HEMA/BIS 0.2 80 100 1 50 60' y A/W y 
T DAU/BIS 0.2 80 100 1 50 60' y A/W y 
Q HEMA/BIS 0.2 80 100 1 50 5' y W y 
R DAU/BIS 0.2 80 100 1 50 5' y W y 
N HEMA/BIS 0.1 80 100 1 50 60' y A/W   
O DAU/BIS 0.1 80 100 1 50 60' y A/W   
K DAU/BIS 0.1 80 100 1 50 5' y W   
U HEMA/BIS 0.1 80 100 1 50 60' y A/W y 
V DAU/BIS 0.1 80 100 1 50 60' y A/W y 
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2.5.6.2 Dynamic Light Scattering analysis 
DLS analysis was performed on the synthesised samples. Results are reported 
in Tab. 2-6: 
Tab. 2-6. DLS results for size (Z average ± standard deviation) and 
Polydispersion Index (PdI). 
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A1 HEMA/BIS 1 46 5' W   72 ± 65 0.9 
A2 HEMA/BIS 1 46 10' W   167 ± 35 0.4 
A3 HEMA/BIS 1 46 30' W   684 ± 100 0.2 
A4 HEMA/BIS 1 46 60' W   313 ± 150 0.3 
C HEMA/BIS 1 46 10' W   174 ± 14 0.4 
D HEMA/BIS 1 46 10' W   105 ± 44 0.6 
B1 HEMA/BIS 1 46 5' W   194 ± 52 0.6 
B2 HEMA/BIS 1 46 10' W   145 ± 47 0.8 
G HEMA/BAP 1 40 5' W   232 ± 43 0.6 
E1 HEMA/BIS 1 72 5' W   155 ± 10 0.7 
E2 HEMA/BIS 1 72 10' W   187 ± 54 0.7 
H1 HEMA/BAP 1 67 5' W   79 ± 29 0.7 
H2 HEMA/BAP 1 67 10' W   113 ± 19 0.4 
F HEMA/BIS 1 80 5' W   163 ± 15 0.3 
P HEMA/BIS 1 80 5' W y 153 ± 12 0.2 
L1 HEMA/BIS 0.2 80 10' A/W   110 ± 7 0.2 
L2 HEMA/BIS 0.2 80 60' A/W   147 ± 2 0.2 
L3 HEMA/BIS 0.2 80 18h A/W   121 ± 2 0.2 
M1 DAU/BIS 0.2 80 10' A/W   211 ± 18 0.3 
M2 DAU/BIS 0.2 80 60' A/W   164 ± 15 0.2 
M3 DAU/BIS 0.2 80 18h A/W   129 ± 4 0.2 
I1 HEMA/BIS 0.2 80 5' W   172 ± 18 0.2 
I2 HEMA/BIS 0.2 80 60' W   192 ± 10 0.3 
J DAU/BIS 0.2 80 5' W   180 ± 62 0.4 
S HEMA/BIS 0.2 80 60' A/W y 174 ± 3 0.1 
T DAU/BIS 0.2 80 60' A/W y 120 ± 10 0.4 
continue… 
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…continue 
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Q HEMA/BIS 0.2 80 5' W y 131 ± 11 0.4 
R DAU/BIS 0.2 80 5' W y 183 ± 17 0.3 
N HEMA/BIS 0.1 80 60' A/W   208 ± 32 0.2 
O DAU/BIS 0.1 80 60' A/W   239 ± 10 0.2 
K DAU/BIS 0.1 80 5' W   219 ± 24 0.3 
U HEMA/BIS 0.1 80 60' A/W y  245 ± 18 0.2 
V DAU/BIS 0.1 80 60' A/W y 301 ± 10 0.2 
 
Here following the systematic evaluation of the effect of the variation of 
conditions explored in nanoparticles production. 
 
 
 
Fig. 2-10. nps size modification due to different experimental conditions in 
recipes containing 1% of total monomers (1%T). PdI values are the red numbers 
above the bars. 
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Fig. 2-10 shows the tendency of the size of nps to increase with a longer 
polymerisation times in Tris buffer (first four bars). 
Reducing the initiators content increases the standard deviation and the 
polydispersity of the sample.  
Avoiding stirring also had an effect on the standard deviation and on 
polydispersity; moreover, turbidity of the reaction mixture appeared sooner 
when the sample was not stirred (20 mins instead of 25). The turbidity means 
the size has increased above 1 micron, thus it can be seen with the naked eye. 
The use of a higher cross-linker percentage does not induce size shrinkage or 
enlargement on HEMA/BIS nps, but it clearly shrinks HEMA/BAP ones, 
probably due to different mechanical properties. Bis-acryloyl piperazine was 
also shown to provide slightly larger pores in gels (Hochstrasser DF, 1988). In 
general a higher cross-linker amount helps MIP cavities to retain their shape by 
making the structure more rigid and the use of an 80%C composition gave good 
results both for size and polydispersity. 
Even though HEMA/BAP particles were smaller than those of HEMA/BIS, they 
had a higher PdI and batch to batch synthesis was less reproducible. 
Literature reports a controlled size increase through the “post dilution method”, 
by which dilution of the reaction mixture is made just before the gelation point to 
reach a %T lower than critical concentration (Wulff G, 2012). This method could 
be mimicked by using low %T from the beginning or a worse solvent, in which 
particles can precipitate when they reach a size large enough to not stay in 
suspension. 
The initial recipe modified for cross-linker percentage (80%C instead of 46%C) 
was thus subjected to the following experimental variations: lower %T, solvent 
change and functional monomer change.  
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Fig. 2-11. nps size modification due to the variation of total monomers content 
%T. 
In Fig. 2-11 the effect of total monomers content on nps size is shown. The first 
part of the Figure (blue bars) reports results obtained in Tris buffer at low 
polymerisation time, while the second part (green bars) concerns experiments 
made in ACN/W at higher polymerisation time. No extended polymerisation time 
was available for synthesis in Tris buffer because solutions became turbid for 
the same monomer composition, indicating the presence of micron-size 
particles.  
Raising the amount of monomers had a slightly shrinking effect on the nps. The 
most interesting effect of using a lower monomer content is however the low PdI 
of the samples, resulting above 0.3 only in 3 recipes on 18 with %T≤0.2 (Tab. 
2-6). This fact was already observed by Wulff et al., who reported a higher 
molecular weight and polydispersity for hydrogels produced with high 
crosslinking and higher amounts of monomers (Wulff G, 2012). This significant 
improvement suggests the use of a low monomer amount in the progress of the 
analysis, and polydispersity issues will be not further considered. 
The effect of the solvent was subsequently explored (Fig. 2-12). ACN/Water 9:1 
v/v was chosen as dispersing media. In order to facilitate the dissolution of the 
reagents, these were firstly added of 1 volume of water, then diluted with 9 
volumes of acetonitrile.  
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Fig. 2-12. Effect of the solvent on nps size. 
 
The most interesting effect of the use of ACN/Water 9:1 v/v is its property of 
keeping the size of the particles in the nano range, without generating turbidity 
(thus allowing particles to grow to the micro range ) as happens in Tris buffer, at 
least at low total monomer amount (less than 1%T). This can be possibly a 
result of its poor solubilizing properties with respect to the growing particle, that 
cannot grow too much in solution before precipitation (Wulff G, 2012). This is 
evidenced by the clear aspect of the solutions after 18h (1000 min) of reaction 
and by the stopped nps growth in 10 min, 60 min and 18h of reaction (Fig. 
2-12). A decrease in nps size for longer polymerisation time was also observed 
with the use of DAU monomer. This fact can be explained with the faster 
kinetics of DAU in being incorporated in the growing particles: an initial fast 
production of particles consumes the monomers, that remain in lower 
concentration in solution but still in presence of an excess of initiators. The next 
step was thus the exploration of the effect of monomer substitution from HEMA 
to DAU. 
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Fig. 2-13. Comparison of different functional monomers. 
 
There was not a high size variation nanoparticle between the use of HEMA and 
DAU, both in Tris buffer and ACN/W for short and long polymerisation times 
(Fig. 2-13). Anyway DAU shows a faster polymerisation kinetics than HEMA, 
with a turbidity point (visible particles in the reaction mixture) of 3min at 1%T 
and 15 min at 0.2% in TRIS buffer (HEMA  gives turbidity in 20 min with the first 
recipe and remains transparent for longer than 60 min with the second). 
Literature generally reports a different kinetics of the different monomers in 
being included in the growing polymer, as well as a different solubility of the 
nanoparticles made with different monomers (Piletska EV, 2008). 
The following step was the study of the effect of the template in the 
polymerisation mixture. The tested recipes are reported in Tab. 2-7 and the 
results in Fig. 2-14. 
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Tab. 2-7. Evaluation of template effect on the size of the nanoparticles. Samples 
F-O (left side of the table) were produced without the template, while  samples P-
Q (right side of the table) were produced by following the same recipes plus the 
addition of template. 
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F HEMA/BIS 1 80 5' 630 160 W 163 ± 15 0.3 P 80 153 ± 12 0.2 
I1 HEMA/BIS 0.2 80 5' 126 32 W 172 ± 18 0.2 Q 16 131 ± 11 0.4 
J DAU/BIS 0.2 80 5' 126 32 W 180 ± 62 0.4 R 16 183 ± 17 0.3 
L2 HEMA/BIS 0.2 80 60' 126 32 ACN/W 147 ± 2 0.2 S 16 174 ± 3 0.1 
M2 DAU/BIS 0.2 80 60' 126 32 ACN/W 164 ± 15 0.2 T 16 120 ± 10 0.4 
N HEMA/BIS 0.1 80 60' 63 16 ACN/W 208 ± 32 0.2 U 8  245 ± 18 0.2 
O DAU/BIS 0.1 80 60' 63 16 ACN/W 239 ± 10 0.2 V 8 301 ± 10 0.2 
 
 
Fig. 2-14. nps size modification due to the addition of Fmoc-pTyr in molar ratio 
1:2 with respect to the functional monomer. 
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The presence of pTyr in the polymerizing mixture does not change significantly 
the dimensions of the nanoparticles. This “template effect” is instead reported in 
some other literature examples (Yoshimatsu K, 2012). 
2.5.6.3 Yield evaluation of small-scale synthesised nanoparticles 
Reaction yield was measured for some recipes (Tab. 2-8). The choice was 
made depending on the size of the nanoparticles and the Polydispersity Index. 
 
Tab. 2-8. Yield of reaction for some chosen recipes. The lyophilised volume 
corresponds to 10ml of the initial solution.  
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H1 HEMA/BAP 1 67 5' W 2.8 2.8 
F HEMA/BIS 1 80 5' W 2.3 2.3 
L1 HEMA/BIS 0.2 80 10' A/W 0.1 0.5 
L2 HEMA/BIS 0.2 80 60' A/W 0.5 2.5 
L3 HEMA/BIS 0.2 80 18h A/W 1 5 
M1 DAU/BIS 0.2 80 10' A/W 0.9 4.5 
M2 DAU/BIS 0.2 80 60' A/W 0.6 3 
M3 DAU/BIS 0.2 80 18h A/W 1.1 5.5 
I1 HEMA/BIS 0.2 80 5' W 4.1 20.5 
I2 HEMA/BIS 0.2 80 60' W 0.5 2.5 
J DAU/BIS 0.2 80 5' W 0.4 2 
N HEMA/BIS 0.1 80 60' A/W 0.1 0.5 
O DAU/BIS 0.1 80 60' A/W 0.1 1 
K DAU/BIS 0.1 80 5' W 0.1 1 
 
The yields were in the range between 0.5% and 5.5%, with no significant 
difference between preparations made with different monomers (Tab. 2-3). The 
evaluation of the variation in the product amount gave a ±1.0mg of uncertainty. 
Recipes H1, F, L3 and M3, shown in Tab. 2-4 
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Tab. 2-4, seemed to be the most promising to proceed with a large-scale 
synthesis, with the intention of not excluding the use of any monomer or 
solvent. Recipes I2 and J, even though seemly promising, would have required 
a huge amount of starting material to produce enough polymer. Recipe I1 
seems to be an experimental deviation (error in the synthesis step, because 
weight measurement on another part of the solution gave the same result), in 
fact a longer polymerisation time gave a lower amount of product.  
2.5.6.4 AFM images 
The four samples chosen to be produced on a larger scale and thus subjected 
to rebinding experiments were analysed by AFM. Images were taken for non-
dialysed samples. Dialysed samples did not show the presence of any particles 
on the mica surface both with the same immobilisation method used for non-
dialysed samples and by doubling the contact time from 5 to 10 min. 
 
The next pictures represent AFM images of a sample prepared with the recipe 
“F” through the procedure explained in the section “materials and methods”. 
The bar on the right side of the pictures is the height of the objects expressed in 
nanometers. 
 
Fig. 2-15. A 50 μm x 50 μm image of sample “F” (HEMA/BIS 1%T, 80%C, 5 min of 
polymerisation in water). 
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Fig. 2-16. A 20 μm x 20 μm image of sample “F”. 
 
 
Fig. 2-17. A 5 μm x 5 μm image of sample “F”. 
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Fig. 2-18. A 1 μm x 1 μm image of sample “F”. 
 
 
Fig. 2-19. A 150 nm x 150 nm image of sample “F”. 
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The particles show a flat, irregular shape, with few aggregates present. The size 
range is approximately from 20 nm x 2 nm (width x height) to 200 nm x 20 nm. 
Another immobilisation method was tried on the same sample, employing 
NaHCO3 buffer (200mM pH 9.0) 1:1 v/v instead of ethanol. The results are 
visualised in the following pictures. 
 
 
Fig. 2-20. A 5 μm x 5 μm image of sample “F” immobilised on the mica dish with 
a NaHCO3 buffer. 
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Fig. 2-21. A 2 μm x 2 μm image of sample “F” immobilised on the mica dish with 
a NaHCO3 buffer. 
 
 
Fig. 2-22. A 1 μm x 1 μm image of sample “F” immobilised on the mica dish with 
a NaHCO3 buffer. 
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A comparison of the two immobilisation methods shows a tendency to 
aggregation with the use of the basic buffer instead of ethanol. The other 
samples were therefore analysed through immobilisation after a 1:1 v/v dilution 
with ethanol.   
 
The next pictures represent AFM images of a sample prepared with the recipe 
“H1” through the procedure explained in the section “materials and methods”. 
 
 
Fig. 2-23. A 50 μm x 50 μm image of sample “H1” (HEMA/BAP 1%T, 67%C, 5 min 
of polymerisation in water). 
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Fig. 2-24. A 20 μm x 20 μm image of sample “H1”. 
 
 
Fig. 2-25. A 10 μm x 10 μm image of sample “H1”. 
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Fig. 2-26. A 10 μm x10 μm image of sample “H1” with semi-contact error mode 
acquisition, to put in evidence changes in height. 
 
 
 
Fig. 2-27. A 5 μm x 5 μm image of sample “H1”. 
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Fig. 2-28. A 5 μm x 5 μm image of sample “H1” with 3D image elaboration. 
 
The particles show a flat shape, with regular distribution on the surface.  
The next pictures represent AFM images of a sample prepared with the recipe 
“L3” through the procedure explained in the section “materials and methods”. 
 
 
Fig. 2-29. A 50 μm x 50 μm image of sample “L3” (HEMA/BIS 0.2%T, 80%C, 18 
hours of polymerisation in ACN/water 9:1 v/v). 
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Fig. 2-30. A 20 μm x 20 μm image of sample “L3”. 
 
 
Fig. 2-31. A 5 μm x 5 μm image of sample “L3”. 
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Fig. 2-32. A 5 μm x 5 μm image of sample “L3” with semicontact error 
acquisition, to put in evidence changes in height. 
 
 
Fig. 2-32. A 2 μm x 2 μm image of sample “L3”. 
 
The particles show a flat shape, with more aggregates than the samples 
prepared in Tris buffer. Moreover, fewer particles are present, probably due to 
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the fact that the particles were initially immersed in ACN/W instead of Tris 
buffer. This could have hampered the adsorption of the particles onto the mica 
surface. 
 
The next pictures represent AFM images of a sample prepared with the recipe 
“M3” through the procedure explained in the section “materials and methods”.  
 
 
 
Fig. 2-33. A 50 μm x 50 μm image of sample “M3” (DAU/BIS 0.2%T, 80%C, 
polymerisation of 18 hours in ACN/water 9:1 v/v). 
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Fig. 2-34. A 20 μm x 20 μm image of sample “L3”. 
 
 
Fig. 2-35. A 5 μm x 5 μm image of sample “L3”. 
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Fig. 2-36. A 5 μm x 5 μm image of sample “L3” with semicontact error-mode 
acquisition, to put in evidence changes in height. 
 
 
Fig. 2-37. A 5 μm x 5 μm image of sample “L3” with 3D image elaboration. 
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Fig. 2-38. A 1 μm x 1 μm image of sample “L3”.  
 
The particles show a flat shape, similar to what can be observed in the sample 
prepared with recipe “L3”. Few particles are actually present, probably due to 
the fact that the particles were initially immersed in ACN/W instead of Tris 
buffer. This could have hampered the adsorption of the particles onto the mica 
surface. 
The next flanked pictures represent the comparison of images of the four 
samples at different magnifications. 
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Fig. 2-39. Comparison of the 50 μm x 50 μm magnification images of the four 
samples. 
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Fig. 2-40. Comparison of the 20 μm x 20 μm magnification images of the four 
samples. 
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Fig. 2-41. Comparison of the 5 μm x 5 μm magnification images of the four 
samples. 
 
 
The general appearance of the nanoparticles is flat, with height 1/10 of the 
width. The size range is approximately from 20nm x 2nm (width x height) to 
200nm x 20nm.  
There is a higher density of particles for samples produced with recipes “F” and 
“H1”. One possible explanation can be the solvent: they are dissolved in Tris 
buffer, while samples “L3” and “M3” in ACN/Water 9:1 v/v. This fact could 
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hamper the attachment of the particles onto the mica surface. More aggregates 
are present in samples prepared in ACN/W. 
 
 
 
Fig. 2-42. Comparison of AFM and DLS data on a sample prepared with recipe 
“F” (HEMA/BIS 1%T, 80%C, 5 min of polymerisation in water). The six peaks 
represent the size distribution by number of particles measured by the 
instrument at different times. Measurements are typically made every 3 minutes. 
There is a seemingly comparable size pattern between AFM and DLS data: 
AFM pictures show a general pattern of bigger, evident nanoparticles with 
dimension around 100 nm x 7 nm (width x height) on a layer of smaller particles 
with dimension around 20 nm x 5 nm. A similar pattern seems to emerge from 
DLS data, with a detected population apparently split into two parts: the first 
having a hydrodynamic diameter of approximately 20 nm and the second  of 80 
nm.  
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2.5.6.5 Yield evaluation of large-scale synthesised nanoparticles 
Here following the assessment of particles presence in concentrated samples. 
The amount of monomer, cross-linker and pTyr indicated in the table are the 
theoretically present in 1mL of sample if all the starting material was converted 
to nanoparticles. The cross-linker content was 80%C (mol/mol) for all the 
recipes. 
Tab. 2-9. Weight of particles in large-scale synthesised samples. 
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F HEMA/BIS 1 97.4 20.6  W 1.0 
F  + Fmoc-pTyr HEMA/BIS 1 97.4 20.6 38.2 W 0.0 
H1 HEMA/BAP 1 88.4 29.6  W 0.3 
H1+ Fmoc-pTyr HEMA/BAP 1 88.4 29.6 53.2 W 0.5 
L3 HEMA/BIS 0.2 19.5 4.1  A/W 0.0 
L3+ Fmoc-pTyr HEMA/BIS 0.2 19.5 4.1 7.7 A/W 0.9 
M3 DAU/BIS 0.2 19.5 4.5  A/W 0.2 
M3+ Fmoc-pTyr DAU/BIS 0.2 19.5 4.5 7.7 A/W 0.3 
 
The results show a proportionally lower amount of material produced on a large 
scale with respect to the amount prepared on a small scale (from 2 to 10 times 
less). This reduced efficiency could be due to the reduced amount of light that 
reaches the reagents. The glass of a bottle is in fact thicker than the glass of a 
vial and the reagents are in media less exposed to the light due to the greater 
volume of liquid. 
2.5.6.6 Cleaning of polymers prepared with standard bulk synthesis 
Only HEMA/BIS and DAU/BIS in Tris buffer were prepared with a standard 
synthesis method to evaluate binding properties. Here following the graphs of 
the cleaning of the polymers. The cleaning proceeded until there was no further 
decrease of the signal (Abs< 0.05). 
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Fig. 2-43. Cleaning of HEMA/BIS NIP and MIP. 
 
 
Fig. 2-44. Cleaning of DAU/BIS NIP and MIP. 
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After cleaning the samples were dried on a cellulose filter paper for 72h. The 
amount of polymer is reported in Tab. 2-10 with the corresponding yields:  
Tab. 2-10. Amount and yield of the polymers prepared with standard bulk 
synthesis. 
 
HEMA/BIS MIP HEMA/BIS NIP DAU/BIS MIP DAU/BIS NIP 
Amount (mg) 216 143 43 118 
Yield % 43 29 9 24 
 
The amount of DAU/BIS MIP was not sufficient to perform rebinding 
experiments, which were therefore only carried out on HEMA/BIS polymers. An 
optimisation of the synthesis conditions has to be made in order to produce a 
greater amount of material.  
2.5.6.7 Rebinding experiments  
Results of testing presented here present the calibration curve for pTyr and the 
graph showing the evaluation of pTyr binding properties of HEMA/BIS NIP and 
MIP. The measurements were made in triplicate. 
 
Fig. 2-45. Calibration curve for increasing concentration of pTyr. 
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Fig. 2-46. Saturation curve for increasing concentration of pTyr. 
From the graphs it emerges that the MIP polymer has a saturation behaviour, 
while NIP definitely increases the substrate incorporation at increasing 
concentrations. The capacity of the MIP resin tends to settle around 3 μg/mg 
resin (11 nmol/mg). The apparent better functioning of NIP polymer with respect 
to MIP could be explained with the presence of residual Fmoc-pTyr in the 
imprinted polymer, that saturates binding sites and repels substrate with the 
same charge. A more extensive washing of the polymer should therefore be 
tried to improve the MIP behaviour. Another possibility is the different structure 
of the NIP and MIP polymers, with the template contributing to the formation of 
less accessible binding sites.  
2.5.6.8 Cleaning of polymers after rebinding 
The graph shown here reports the cleaning passages. Absorbance data of NIP 
and MIP were put together given their identical behaviour in pTyr release. 
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Tab. 2-11. Absorbance data at 272nm for the cleaning solutions. 
 HEMA/BIS and 
HEMA/BIS + pTyr 
time (h) total time (h) 
MeOH/HCl 1:1 
0.33 2 2 
MeOH/HCl 1:1 0.31 1 3 
MeOH/HCl 1:1 0.24 15 18 
MeOH/HCl 1:1 0.16 1 19 
MeOH/HCl 1:1 0.12 1 20 
MeOH/HCl 1:1 0.06 1 21 
MeOH/HCl 1:1 0.04 1 22 
MeOH/HCl 1:1 0.18 15 37 
MeOH/HCl 1:1 0.05 1 38 
MeOH/HCl 1:1 0.003 2 40 
Tris 0.001 2 42 
Tris   final final 
 
 
Fig. 2-47. Trend of pTyr amount extracted from the polymers. 
Two days were necessary for the complete cleaning of the polymers from the 
substrate pTyr (Abs <0.01). 
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2.5.6.9 Rebinding after cleaning 
The graph presented here shows the results of rebinding experiments after 
polymer cleaning. 
Tab. 2-12. Absorbance data obtained in rebinding experiments. 
 
H/B (NIP) 
μg/ml 
Abs 
Conc 
(μg/ml) 
C Bound 
(μg/ml) 
C Bound 
(μg/mg) 
13 0.039 12 0.71 0.14 
26 0.070 24 1.92 0.38 
52 0.136 49 2.81 0.56 
130 0.337 126 4.33 0.87 
260 0.667 251 8.78 1.76 
 
H/B pTyr (MIP)  
μg/ml 
Abs 
Conc 
(μg/ml) 
C Bound 
(μg/ml) 
C Bound 
(μg/mg) 
13 0.038 12 1.09 0.22 
26 0.076 26 -0.37 -0.07 
52 0.138 50 2.04 0.41 
130 0.344 128 1.67 0.33 
260 0.676 255 5.35 1.07 
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Fig. 2-48. Graph reporting the saturation of NIP and MIP polymers. 
 
From the graph it can be noted that MIP tends to bind less substrate than NIP. 
The binding capacity after cleaning was shown to be much lower than before 
the cleaning, being 6 times less.  
The complete saturation of the polymers could not be reached, anyway higher 
concentrations of substrate would give absorbance values out of the range of 
confidence of the instrument (0.001<Abs<1.0). 
2.6 Conclusion 
A photopolymerisation method for the production of MIP nanoparticles was 
evaluated here. 
The method was tested under different conditions, including use of different 
monomers, cross-linkers and solvents. 
A remarkable result, already reported by Wulff et al. (Wulff G, 2012), regards 
the effect of a “bad” solvent, that keeps the size of the particles small avoiding 
their continuous growth in solution through precipitation.  
Good results both for size and polydispersity were obtained with the following 
recipe (“F”): HEMA/BIS 1%T, 80%C, MB 100µM, TSIA 1mM, DPI 50μM, 
agitation, 5 min polymerisation. Zave was 163 ± 16 nm and PdI 0.332 ± 0.101, 
with good reproducibility.  
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Good size results were obtained also with the use of BAP as cross-linker (“G” 
recipe: Zave 81 ± 29 nm), but for the price of a higher polydispersity (PdI 0.756 
± 0.219).  
Lowering the monomers content from 1% to 0.2%  brings unexpected 
enlargement of nanoparticles both in TRIS buffer and acetonitrile/water 9:1 v/v 
(recipes F-I, P-Q, Fig. 2-10).  
DAU shows faster polymerisation kinetics than HEMA in TRIS buffer, having a 
turbidity point of 3 min at 1%T and 15 min at 0.2%T (HEMA does not give 
turbidity for both recipes after 60 min). Moreover DAU nanoparticles are in 
general bigger than those incorporating HEMA (Fig. 2-11).  
The addition of Fmoc-pTyr does not produce a significant change in size or 
polydispersity (recipes F-P, L-S and M-T, Fig. 2-14). 
The yields were between 0.5% and 5.5%, with no significant difference between 
the use of different monomers (Tab.2-8).  
HEMA/BIS recipe was produced with a standard bulk synthesis and subjected 
to rebinding experiments. The results show a saturation behaviour for the MIP 
and the tendency to accumulate the substrate for the NIP. The binding capacity 
for the MIP was 3 μg/mg (11 nmol/mg) resin. 
The results can be considered as still preliminary, with the perspective to 
evaluate binding characteristics for other recipes.  
Nevertheless the DLS analysis showed that our method of synthesis is effective 
in the production of particles with size around 100 nm, confirmed through AFM 
microscopy. Moreover an interesting result was the low polydispersity of the 
particles that in many cases was below 0.2. 
AFM showed particles with a flattened shape, probably due to the fact that a 
hydrogel is soft and the combined effect of gravity, surface attraction and 
pressure of the tip of the probe lower their height (Weisenhornt AL, 1993).  
The future perspectives of this research line consist of extending the evaluation 
of the binding properties to other recipes. In particular, testing the properties of 
the nanometric format (the four recipes produced on large scale) would give us 
an indication of the possibility of production of a valid alternative material to 
phosphospecific antibodies.  
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A peculiar characteristic of MIPs is in fact the possibility of being shaped around 
a template creating a cleft complementary to it: in the case of phosphopeptides 
this could mean creating a material with complementarity not only for a 
phosphate group but also for an extended epitope, such as an aminoacidic 
sequence flanking a phosphoamino acid. This is an enhanced characteristic 
with respect to the usual resins employed in phosphoproteomics, such as TiO2, 
that are specific only for the phosphate group (Helling S, 2011). 
Not many examples of phosphoamino acid imprinting can be found in the 
literature, and these studies can be considered directed towards the creation of 
a first generation of materials. Helling et al. (Helling S, 2011) tested the 
chromatographic performance of a crushed monolith with respect to TiO2, 
finding a significant advantage in the selectivity for pTyr down to the low fmol 
level with respect to other amino acids, plus a preference for pTyr containing 
peptides, recovering a 18-fold more p-angiotensin II than the non-
phosphorylated peptide (Helling S, 2011). A further advantage of the 
nanometric format over microparticles could be the enhanced characteristics 
with respect to the time of diffusion, thus reducing the time for analysis, plus a 
better homogeneity of the binding sites.  
In practice, the next experiments will be to test the material against pTyr-
containing peptides to evaluate its selectivity towards the non-phosphorylated 
counterparts and pSer/pThr containing peptides. A stable suspension with 
known concentration of nano-MIPs could be directly added to a peptide mixture 
and ultrafiltered after incubation: the solid material will contain bound 
phosphopeptides that can be subsequently extracted with a proper choice of 
buffer.   
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3 Chapter  
DEVELOPMENT OF AN SPR BIOSENSOR FOR HEPCIDIN 
HORMONE 
3.1 Introduction 
Iron homeostasis related disorders have a high incidence in the population. 
Both anemias, in which iron is deficient, affecting at least 500,000,000 people in 
the world, including at least 2-5% of adolescent at every latitude (Andrews NC, 
1999), and iron overload disorders, as Hereditary Haemocromatosis (HH) are 
widespread. The C282Y allele on the HFE gene, which is mainly linked to HH, 
occurs in 5-10% of the European population (Andrews NC, 1999). It was 
demonstrated that iron homeostasis is regulated by the 25 amino acid peptide 
hormone Hepcidin (Hepc) and that urinary and blood levels of Hepc are 
associated with dis-regulation of iron metabolism (Pigeon C, 2001). 
Hepcidin regulates iron export from enterocytes and macrophages by binding 
the only known iron export protein, ferroportin (Nemeth E, 2004). It is 
synthesised in the liver as an 84-amino acid pre-pro-hormone and matured by 
proteolysis through a furin cleavage to generate the biologically active 25-aa 
peptide (Hepc-25) that is secreted into circulation (Gagliardo B, 2009). Hepc-25 
leaves the body via secretion through the kidneys (Park CH, 2001). 
In contrast to serum, where the Hepc-25 (2789.4 Da) form is detected almost 
exclusively, urine also contains N-terminally truncated peptides of 22 amino 
acids (Hepc-22; 2436 Da) and 20 amino acids (Hepc-20; 2191.7 Da) (Park CH, 
2001, Krause A, 2000).  
Structurally, hepcidin shows a secondary amphipathic structure and is 
particularly rich in basic amino acids that confer a positive charge with an 
isoelectric point of 8.2 (Krause A, 2000). The eight cysteine residues contained 
within hepcidin form four disulfide bridges (Fig. 3-1) (Park CH, 2001). 
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Fig. 3-1. NMR structure of the major form of human hepcidin The amino and 
carboxy termini are labelled as N and C respectively Disulfide bridges are in 
yellow (This research was originally published in Journal of Biological Chemistry 
Jordan JB, Poppe L, Haniu M, Arvedson T, Syed R, Li V, Kohno H, Kim H, Schnier 
PD, Kim H, Schnier PD, Harvey TS, Miranda LP, Cheetham J, Sasu BJ, Journal of 
Biological Chemistry 2009, 284, 24155, 24167 © The American Society for 
Biochemistry and Molecular Biology. 
 
Because hepcidin levels reveal important clinical information about pathological 
states, measurement of hepcidin in urine or plasma as a biomarker may be 
interesting to apply in clinical practice. 
Despite significant efforts, the development of a robust assay to detect hepcidin 
proved to be problematic. Initially, hepatic hepcidin mRNA expression in the 
liver was successfully used as a marker, but liver biopsies are rarely clinically 
indicated (Kemna EHJM, 2008). Immunoassays are commercially available for 
prohepcidin (DRG Diagnostics, Marburg, Germany), however, the assay does 
not recognise the biologically active Hepc-25 (Frazer DM, 2009). By contrast, 
the only available immunoassay against Hepc-25 is not widely available yet as 
a commercial product (Ganz T, 2008, Koliaraki V, 2009, Schwarz P, 2011). 
Therefore, several groups have developed assays to detect Hepc-25 based on 
mass spectroscopy (Ward DG, 2008, Bozzini C, 2008, Kemna E, 2005, Kemna 
EH, 2007, Tomosugi N, 2006, Altamura S, 2009). 
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These latter techniques have the disadvantage to be quite expensive and 
demanding in terms of sophisticated instrumentation and dedicated staff. 
Moreover, MS methods revealed the presence, in biological fluids, of non-
functional truncated isoforms of Hepc (e.g. Hepc-22 and Hepc-20), which 
further complicated the interpretation of the most advanced immunological 
assays. These forms, in fact, are detected by the immunoassays but do not 
intervene in iron balance regulation (Swinkels D, 2008). 
It can be concluded that, notwithstanding the very latest progress, a method for 
blood and urine Hepc measurement having the characteristics of accuracy, 
ease of implementation, and large scale distribution at fairly low cost is still not 
available. 
De Domenico et al. (I De Domenico, 2008) identified the hepcidin-binding 
domain (HBD, Fig. 3-2) on ferroportin and showed that a synthetic 20 amino 
acid peptide corresponding to the HBD summarises the characteristics and 
specificity of hepcidin binding to cell-surface ferroportin. They subsequently 
developed a competitive assay to measure hepcidin concentrations in small 
volumes of biological fluids. 
 
 
Fig. 3-2. Predicted topology of ferroportin (Fpn) The structure of Fpn is based on 
the study of Liu et al, 2005 [adapted from ref.108]. We can note the HBD 
synthetically mimicked. 
Our attempt is to improve the measurement of the hepcidin levels in body fluids 
by developing a point-of-care and label-free assay based on the affinity 
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between hepcidin and this synthetic peptide. For the purpose we exploited the 
Surface Plasmon Resonance (SPR) technique (see next paragraph) and the 
immobilisation of the synthetic ligand on CM5 Biacore chips. These chips 
present a carboxymethyl dextran matrix on the surface, to which the N-terminal 
of HBD can be bound through the use of EDC/NHS chemistry. 
The sequence of the wild-type HBD is FDCITTGYAYTQGLSGSILS (pI=3.8). To 
increase solubility, the peptide was synthesised with two arginines added at the 
amino and carboxyl termini (pI=10.0). The arginines did not affect the 
specificity, temperature dependence, or affinity of HBD for hepcidin (Liu X, 
2005). The presence of these extremities could favour the binding of hepcidin, 
freeing amino acids able to link the hormone. We tested the effectiveness of the 
peptide bait linking it to the chip and evaluating the instrumental response to 
different concentrations of hepcidin-25. 
3.2 Surface Plasmon Resonance 
Surface Plasmon Resonance is a biosensing technique widely employed in 
testing the affinity between ligands and analytes. Biosensors can be defined as 
“…devices comprising a biologically sensitive material immobilised in intimate 
contact with a suitable transducing system to convert the biochemical signal into 
a quantifiable and processable electric signal” (Lowe CR, 1984). The physical 
phenomenon at the core of the SPR system is the variation of refractive index of 
a dielectric medium in contact with a metal (Cooper MA, 2009). Usually gold is 
chosen for its better performance and inertness.  
When a linearly polarised beam of light (polarisation parallel to the plane of 
incidence) hits the surface of the metal, the radiation is totally internally 
reflected if the angle of incidence is higher than the critical angle. At a certain 
angle of incidence, called the SPR angle (ΘSPR), the component of the wave of 
light parallel to the surface excites the polaritons, waves of electrons along the 
surface of the metal, if their wavelength corresponds to the wavelength of the 
incident light (i.e. there is resonance). In this case an evanescent field is 
generated at the interface between metal and medium. The amplitude of this 
field decays exponentially from the surface and is sensed usually at a maximum 
distance of ~100 nm from the surface. The SPR angle depends on the 
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wavelength, on the metal, on the temperature and on the polarisability of the 
medium at the interface with the metal, strictly connected to its refractive index 
(n) by the Eq. 3-1:  
 
 
Eq. 3-1. 
where εr is the relative permittivity of the material and µr is its relative 
permeability. 
This absorption is evidenced by a minimum of reflected light that arrives to a 
detector (usually a photodiode array) at the SPR angle (ΘSPR). The dependence 
of ΘSPR from the refractive index of the medium in contact with the metal is the 
principle at the basis of the system. By immobilising a ligand on the surface, for 
example, the binding events of analytes to the ligand can be monitored through 
the variation of the refractive index, proportional to the mass of analyte in 
proximity to the interface metal/dielectric (Fig. 3-3). 
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Fig. 3-3. Representation of the SPR principle. The SPR angle (angle at which the 
incident light is absorbed and not totally reflected) depends on the refractive 
index of the medium in contact with the metal layer on which the light impinges. 
This refractive index is directly proportional to the mass of analyte bound to the 
metal surface (Picture taken from: Wikipedia).    
 
The variation of n is converted in Responsive Units (RU), proportional to the 
mass of analyte. In the case of proteins, these molecules all have a similar n, 
thus a binding event or simply the presence of any protein in proximity of the 
surface generates a signal proportional to the mass: 1RU corresponds to 1 
pg/mm2 of protein. The binding event is actually a dynamic process that is 
expressed by a profile of RU variation, called a sensorgram (Fig. 3-4).  
 
 
Fig. 3-4. Typical SPR sensorgram depicting a binding event (picture taken from: 
Biacore website). 
 
When a solution of analyte is injected in the system and arrives to the detecting 
zone, firstly a variation of RU due to the different refractive index of the media is 
sensed: this is called a “bulk effect”. 
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The binding of the analyte to the surface is subsequently detected, generating 
an increase of the signal that finally reaches a plateau, when a dynamic 
equilibrium occurs. By stopping the injection of analyte a decrease of the signal 
is detected, and this decrease depends on the affinity between analyte and 
ligand. With SPR the strength of interaction between partners, one of which is 
immobilised on the surface, can be evaluated, as explained in Par. 3.4. Kinetic 
constants can also be measured by fitting the profile of binding and detachment 
(Fig. 3-4).  
Biacore furnishes chips with different matrixes on a golden layer, to meet the 
need of the researchers. For example a carboxymethylated matrix gives good 
performance with proteins by furnishing sites of attachment through EDC/NHS 
chemistry and by minimizing the non-specific binding, a relevant problem when 
SPR technique is used with complex matrixes. 
A commonly used Biacore chip is CM5, with a carboxymethylated highly 
branched matrix able to furnish multiple points of attachment to the ligand 
molecules.  
3.3 Materials and methods 
3.3.1 Reagents 
CM5 chips were purchased from Biacore (Sweden). Ethanolamine (Eth), 1-
ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), N-hydroxysuccinimide 
(NHS) were from Sigma Aldrich (UK). Synthetic Hepc-20 and Hepc-25 were 
purchased from AbCam (UK); peptide ligands (HBD 20-mer and RR-HBD-RR 
24-mer) are custom made at Peptide 2.0 (USA). All reagents and solvents were 
used at analytical grade. 
3.3.2 Peptide immobilisation on CM5 chips 
The CM5 chips were activated with the coupling mixture EDC/NHS (200 mM/50 
mM) for 75 min (75 µl at 10 µl/min). The peptide RR-HBD-RR was dissolved at 
concentration of 50 µg/mL in 10 mM phosphate buffer at pH 7.0 and flushed for 
12 sec at 10 µL/min flow rate. Quenching of reaction was performed with 1M 
Eth at flow rate 10 µl/min for 25 min (total volume: 25 µl) One channel was kept 
as reference by injecting only Eth after EDC/NHS activation.  
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3.3.3 Hepcidin measurements 
Hepcidin-25 was injected simultaneously in three flow channels of the IFC 
(Integrated Microfluidic Cartridge). A fourth channel was kept as reference. The 
signal from this reference channel was subtracted from the RU response of the 
three channels to give the final value of RU. The chosen concentrations were: 
1, 5, 10, 25, 50, 100 ng/mL. Running buffer was PBS, whose flow was kept at 2 
µl/min.  
3.4 KD estimation 
An estimation of the affinity between the ligand RR-HBD-RR and hepcidin-25 
was attempted through the use of Biacore Biasimulation software.  
Curve-fitting of the experimental data enables the association and dissociation 
rate constants and the equilibrium dissociation constant to be determined. Of 
the models proposed by Biacore®, the “1:1 binding” model was the one that 
gave the best fit (the lowest χ2). It is the simplest model and describes the 
interaction between an analyte A and a ligand B as:  
 
 
Eq. 3-2. 
The association rate ka (in L/(mol s)) corresponding to the number of 
complexes formed per second in a molar solution of HBD and Hepc-25, is 
defined by the formula:  
 
 
Eq. 3-3. 
Where [A], [B] and [AB] are the concentrations of A, B and the AB complex The 
dissociation rate constant kd (in s− 1), corresponding to the portion of the 
complex that dissociates in 1 s, is given by the formula: 
 
 
Eq. 3-4. 
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Association and dissociation actually occur at the same time. Furthermore, 
association is equal to dissociation at equilibrium, resulting in an equilibrium 
dissociation constant of:  
 
 
Eq. 3-5. 
A high KD therefore means that there is low affinity between the analyte and the 
ligand. By fitting the analytical expressions of the response R(t) to the R(t) 
curves in RU obtained in real time by the Biacore® system, it is possible to 
deduce these various constants, ka, kd and KD, that characterise the binding of 
the analyte (Hepc-25 or Hepc-20) to the ligand (RR-HBD-RR). 
3.4 Results and discussion 
3.4.1 Immobilisation 
The maximum amount of ligand to be bound to a CM5 chips was assessed to 
be 5500 ± 500 RU (1000 RU = 1 ng/mm2). The choice was therefore to keep the 
ligand level around 3000 RU, to permit the analyte to ‘sneak’ between the 
immobilised ligands avoiding steric crowding on the chip surface. 
This result was obtained with a 12 µl injection at 10 µl/min flow (Tab. 3-1).  
Tab. 3-1. Immobilised peptide amount in three channels, expressed in RU 
(1000RU=1ng/mm2). 
 
Flow channel 1 Flow channel 2 Flow channel 3 
Peptide (RU) 2800 3700 2250 
 
3.4.2 Detection 
Increasing amounts of hepcidin-25 and hepcidin-20 were injected, starting from 
1 ng/mL increasing to 100 ng/mL. The response for the three channels is 
reported in Tab.. In this case a regenerating solution was not used during the 
experiment between the different injections, because the level of saturation of 
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the surface was minimal compared to the total amount of binding sites available 
(<5% considering the mass of analyte compared to the mass of ligand bound).  
3.4.3 Regeneration 
Different regenerating solutions were tried with the purpose of removing bound 
hepcidin while not to spoil or remove the ligand bound on the chip surface. Salt 
solutions were initially considered, with the idea of a “soft” regeneration. 
Increasing concentrations of NaCl were injected, and finally NaCl 500mM 
proved to be effective for the purpose. Other regenerating solutions (NaOH 1 
mM, 10 mM glycine pH 2.5) had the drawback of significantly reducing the 
binding capacity of the ligand after their use.   
Tab. 3-2. Hepcidin concentrations and relative instrumental response. 
Hepcidins concentration (ng/mL) 
Hepc-25 media 
(RU) 
Hepc-20 media 
(RU) 
1 10 ± 4 5 ± 2 
5 15 ± 3 10 ± 2 
10 21 ± 6 14 ± 3 
25 26 ± 8 16 ± 3 
50 36 ± 9 14 ± 3 
100 67 ± 21 5 ± 2 
 
Fig. 3-5 shows a sensorgram depicting the instrumental response due to 
different concentrations of analyte in a single flow channel. It can be noticed the 
proportionality of slope due to increasing concentrations of analyte. Stabilisation 
of baseline was allowed to occur after every injection. 
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Fig. 3-5. Instrumental response following sequential injections of hepcidin in one 
of the available channels. 
 
The binding curves following the sequential injections of increasing 
concentrations of hepcidin were then superimposed to highlight the 
proportionality of the signal to the presence of hepcidin (Fig. 3-6). 
 
Fig. 3-6. Superimposition of instrumental responses due to increasing 
concentrations of hepcidin-25. 
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The response of the system to the increasing hepcidin concentration was used 
to produce a calibration curve (Fig. 3-7). 
 
 
Fig. 3-7. Calibration curve related to increasing hepcidin-25 concentrations. 
 
The response of the system was linear in the range of concentrations evaluated 
(R2 = 0.98). Sensitivity was moderate (slope = 0.54), as well as the intermediate 
precision (average intra-assay CV% = 29). The specificity against the 
competitor hepcidin-20 is however good, even though not quantified for not 
having reached a saturation value of concentration. Anyway the response for 
hepcidin-20 at the highest concentration measured (100 ng/mL) was 7% than 
the response of hepcidin-25 (Tab.), and this result is therefore encouraging.  
A couple of considerations should be made here: the first one regards the high 
standard deviation of the data, increasing at increasing concentrations. This fact 
could be explained with the big differences on the amount of the immobilised 
fishing ligand on the channels. More experiments with other chips could be 
made to shed light on this problem. Another consideration regards the high 
value of the intercept, meaning that there is a high response at concentration of 
analyte close to zero. An injection of the buffer alone does not give a response 
higher than 2 RU, meaning that it is hepcidin that causes the increase of the 
signal. Anyway the calibration curve tries to fit in a linear fashion data that do 
 129 
not show an exactly linear trend. This could give an estimation of the intercept 
value higher than expected.       
3.4.4 KD estimation 
The evaluation of KD with our data gave us an attempted value of KD of 50 nM, 
consistent with data previously reported for measuements made in solution. De 
Domenico et al., in fact, estimated the value of dissociation constant of RR-
HBD-RR with hepcidin to be 200 nM (De Domenico I, 2008). The small 
difference could be explained by the difference in interaction between partners 
in solution and when a ligand is immobilised on a surface (Cochran S, 2009). 
3.4.5 LLOD estimation 
The Lower Limit Of Detection (LLOD), considered as a signal 3 times the 
standard deviation of the blank (injection of the buffer alone), was assessed to 
be 5 ng/mL. 
3.5 Conclusion 
The clinical relevance of hepcidin quantification is elevated. Therefore, the 
measurement of hepcidin in serum and urine has been identified as a valuable 
parameter for the differential diagnosis of physiopathological states. In iron 
overload syndromes the hepcidin level allows a diagnostic pre-genetic scheme 
to be drawn for grouping of patients (Kaneko Y, 2010). Whereas in anaemic 
patients, a hepcidin level threshold was proposed to be 129.5 μg/L to help 
diagnose iron deficiency in critically ill patients, thus directing them towards an 
appropriate therapy (Lasocki S, 2010). After myocardial infarction the levels of 
hepcidin have been observed to increase both in the ischemic and in the remote 
myocardium; such up-regulation seems to be specifically associated with 
hepcidin, as other iron-regulatory molecules did not show changes, and it was 
hypothesised to correlate with a defence mechanism to reduce iron toxicity and 
thus to reduce the expansion of the infarction (Simonis G, 2010). Hepcidin 
expression does correlate with inflammation and increases with increased 
interleukin-6 (IL6) (Nemeth E, 2004) and is negatively correlated with 
erythropoietin as shown in kidney impairment patients (Ashby DR, 2009). 
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Our results show the ability of the HBD ligand to bind hepcidin-25, indicating the 
possibility of the measurement of the analyte by the use of the SPR technique.  
The system showed poor binding for the competitor hepcidin-20, an interferent 
in the measurement of hepcidin-25 by ELISA, at least for the higher 
concentrations of analytes (Kroot T, 2010). Regarding this aspect our system 
could therefore have a significant advantage.  
SPR is also a rather straightforward technique: once the protocol of analysis 
has been optimised the measurement could be made by non-specialist 
personnel. The system permitted the measurement of hepcidin in the patho-
physiological concentration range of 5-100 ng/L (1.5 – 35 nM), with LLOD of 5 
ng/mL (1.5 nM). This limit is higher compared to c-ELISA (0.01 nM) (Kroot T, 
2010) and similar to that of MS approaches (0.55 – 1.55 nM for SELDI-TOF 
(Swinkels D, 2008), 0.5 nM for WCX-TOF (Kroot T, 2010), 0.75 nM for MALDI-
TOF (Anderson DS, 2010)) but nevertheless can reveal an hepcidin deficit, that 
starts to be pathological at 5 nM (Ganz T, 2008, Galesloot TE, 2011).  
One of the main problems of this technique is to overcome the non-specific 
binding. This is actually the main problem to solve when needing to deal with 
complex matrices such as serum. Some proteins such as albumin have an 
overwhelming presence in blood that can be more than 6 orders of magnitude 
higher than the concentration of disease markers. Its physiological 
concentration is in fact assessed to be 35-50 mg/mL (Anderson NL, 2002), 
while hepcidin concentration was evaluated to be between 5 and 350 ng/mL 
considering both sexes (Ganz T, 2008). The natural proceeding in the method 
development could therefore be the analysis of serum samples after filtration on 
a high MW cut-off membrane. Kobold et al, for example, obtained a recovery of 
hepcidin between 95 and 100% by filtering serum samples on a 10 kDa cut-off 
cellulose acetate membrane (Kobold U, 2008). 
In conclusion, the system under development here described has the potential 
to permit an easy and straightforward measurement of hepcidin in body fluids, a 
highly desired goal of the scientific community. 
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4 Chapter  
GENERAL CONCLUSIONS 
Proteomics showed a pivotal role in the process of the discovery of new 
potential biomarkers for diseases (Calligaris D, 2011). The methods are quite 
well established, but improvements at all levels are needed if we want to dig in 
the subproteome (proteins present in picomolar amount). Disease biomarkers 
are in fact often in this range of concentration in body fluids (Righetti PG, 2005). 
The detection and quantification of established biomarkers can also take 
advantage of biosensing techniques that are emerging as valuable diagnostic 
tools. Their inner potential lays in the possibility of developing the so-called 
point-of-care diagnostics, i.e. directly at the patient’s bedside (Mascini M, 2008). 
The use of proteomics techniques, in particular 2D-PAGE, has been applied 
here to discover up- or down-regulated proteins in umbilical cord serum and 
amniotic fluids of Intrauterine Growth Restricted (IUGR) foetuses. A total of 14 
and 11 proteins were found to be modulated in IUGR umbilical cord serum and 
amniotic fluids respectively. In particular, proteins related to blood pressure, 
coagulation, immunity, oxidative stress and iron/copper metabolism were found 
to be involved in the IUGR pathological picture. Proteomics furnishes a 
snapshot of the whole protein complement in a particular stage of life and/or in 
a particular condition. This is however just the first step: the data obtained in 
this study necessitates a further validation on a larger scale and a deeper 
analysis to shed light on the pathological mechanisms. The final goal is in fact 
to detect diagnostic biomarkers which could help a specific and early diagnosis 
of IUGR. 
The improvement of the analysis methods is at the basis of the process of 
biomarkers discovery. Phosphoproteomics is definitely a subject of importance 
to identify deranged mechanisms, it being involved in so many life processes 
such as signalling, cell duplication and apoptosis. Altered phosphorylation 
pathways are in fact present in pathologies such as cancer, neurodegeneration 
and diabetes (Thingholm TE, 2009).  
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A small step was made here in the production of Molecularly Imprinted Polymer 
nanoparticles (nanoMIPs) for the sequestration of phosphoproteins and/or 
phosphopeptides from complex protein mixtures. The challenge in the 
production of nano-MIPs is in fact to create a valid alternative to antibodies, 
whose cost is nowadays high and stability is low (Ye L, 2008). The experiments 
allowed the definition of a photoactivated synthesis protocol for the production 
of nanoMIPs and in the first experiments to evaluate the efficiency of the 
material towards the binding of phosphotyrosine. The loading capacity of the 
nanoMIPs was assessed. More experiments are however needed in order to 
extend the binding experiments to a wide range of nanoMIPs compositions 
(Wulff G, 2012).  
The field of biosensors is definitely a sparkling one, with many papers published 
in recent years. Biosensors can give a boost to the process of biomarker 
detection, having the potential of miniaturization and thus employment directly 
at the patient’s bedside, when not directly implanted under the skin (Lowe CR, 
2011). An interesting subject for which to devise a biosensor is hepcidin, the 
major regulator of systemic iron homeostasis in mammals. Its quantification 
could be useful in the deepening the knowledge of iron imbalance-related 
diseases, in stratifying patients as well as in monitoring disease progression 
(Castagna A, 2010).  
The detection and quantification of hepcidin-25 was here attempted with by 
employment of Surface Plasmon Resonance as the biosensing technique. A 
protocol for chip preparation was established and a calibration curve in the 
physiopathological range of concentrations was made. Moreover, the affinity 
between hepcidin-25 and its binding domain on ferroportin (HBD) was 
evaluated, assessing the negligible binding of HBD for the competitor hepcidin-
20 above 50 ng/mL. This part of experiments should be considered as 
preliminary, and it has to be extended to the analysis of real samples, with the 
intention of selecting hepcidin as primary analyte to be measured, overcoming 
the hurdle of non-specific binding, in particular of highly abundant proteins of 
serum, such as albumin (Righetti PG, 2003). 
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In conclusion, the field of biomarkers discovery and quantification was here 
explored on three research topics. The results obtained are some steps on the 
path. More steps need to be taken in order to deepen our knowledge of these 
subjects in the near future.   
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